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 Abstract 
 
Lesion of the rat entorhinal cortex denervates the outer molecular layer of the fascia 
dentata followed by layer-specific axonal sprouting of uninjured fibers in the denervated 
zone. One of the candidate molecules regulating the laminar-specific sprouting response in 
the outer molecular layer is the transmembrane chondroitin sulfate proteoglycan NG2. 
NG2 is found in glial scars and has been suggested to impede axonal regeneration 
following injury of the spinal cord.  
The present study adressed the question whether NG2 could also regulate axonal growth in 
denervated areas of the brain. Therefore, (1) changes in NG2 mRNA and NG2 protein 
levels, (2) the cellular and the extracellular localisation of the molecule, (3) the identity of 
NG2 expressing cells, and (4) the generation of NG2-positive cells were studied in the rat 
fascia dentata before and following entorhinal deafferentation. Laser microdissection was 
employed to selectively harvest the denervated molecular layer and combined with 
quantitative reverse transcription-PCR to measure changes in NG2 mRNA amount (6h, 
12h, 2d, 4d, 7d post lesion). The study revealed increases of NG2 mRNA at day 2 (2.5-
fold) and day 4 (2-fold) post lesion. Immunocytochemistry was used to detect changes in 
NG2 protein distribution (1d, 4d, 7d, 10d, 14d, 30d, 6 months post lesion). NG2 staining 
was increased in the denervated outer molecular layer at 1 day post lesion, reached a 
maximum at 10 days post lesion, and returned to control levels within 6 month. 
Interestingly, the accumulation of NG2 protein was strongly restricted to the denervated 
outer molecular layer forming a border to the unaffected inner molecular layer. Using 
electron microscopy, NG2-immunoprecipitate was localized not only on glial surfaces and 
in the extracellular matrix but also in the vicinity of neuronal profiles indicating that NG2 
is secreted following denervation. Double-labelings of NG2-immunopositive cells with 
markers for astrocytes, microglia/macrophages, and oligodendrocytes suggested that NG2-
cells are a distinct glial subpopulation before and after entorhinal deafferentation. 
Bromodeoxyuridine-labeling revealed that some of the NG2-positive cells are postlesional 
generated. 
 
Taken together, the data revealed a layer-specific upregulation of NG2 in the denervated 
outer molecular layer of the fascia dentata that coincides with the sprouting response of uninjured fibers. This suggests that NG2 could regulate lesion-induced axonal growth in 
denervated areas of the brain. 
Introduction 
 
The central nervous system (CNS) of an adult organism is characterized by a large number 
of interconnected neurons that are insulated by glial cells. For many years the adult brain 
was believed to be a stable organ in the sense of a finished end product of the 
developmental process. It was considered "mature" and believed to be incapable of 
regeneration. Ramon y Cajal postulated in 1928: “The functional specialization of the brain 
imposed upon the neurones two great lacunae: proliferative inability and irreversibility of 
intraproto-plasmatic differentiation. It is for this reason that, once the development has 
ended, the fonts of growth and regeneration of the axons and dendrites dried up 
irrevocably. In adult centres the nerve paths are something fixed, ended, immutable. 
Everything may die, nothing may regenerate. Pathologists consider it an unimpeachable 
dogma that there is no regeneration of the central paths, and therefore that there is no 
restoration of the normal physiology of the interrupted conductors in the spinal cord. A 
vast series of anatomico-pathological experiments in animals, and an enormous number of 
clinical cases that have been methodically followed by autopsy, serve as a foundation for 
this doctrine, which is universally accepted today.” (Ramon y Cajal, 1928).  
 
To date, it is widely accepted in neuroscience that the neuronal circuitry of the CNS is 
continuously reshaped in the adult brain. It is this plasticity of the nervous system that 
allows an organism to adapt to changing environments and to react appropriately to 
internal as well as external stimuli. However, focal injury of the CNS as well as 
neurodegenerative diseases damage the adult brain and result in severely impaired 
neuronal function. Although injured CNS axons are, indeed, incapable of regeneration in 
the adult brain, a lesion-induced form of neuronal plasticity exists that may compensate for 
the loss of neurons following injury: “axonal sprouting”. This form of central nervous 
plasticity, where uninjured axons sprout new axon collaterals that reinnervate denervated 
areas, was first observed in the spinal cord (Liu and Chambers, 1958), and in the brain in 
the septum (Raisman, 1969). By now this phenomenon has been documented for several 
species (Cotman et al., 1981), brain regions (Raisman and Field, 1973; Rubel et al., 1981; 
Chen and Hillman, 1982; Wells and Tripp, 1987; Schwegler, 1995), and is now regarded as a naturally occurring reorganization response of the brain to different kinds of lesions 
(Steward, 1994). 
 
It is of fundamental interest to understand the molecular and cellular basis of this lesion-
induced central nervous system plasticity. Understanding this basis may lead to the 
development of novel therapeutic strategies that may help in the treatment of acute brain 
trauma or neurodegenerative diseases. 
 
 
Reorganisation processes after central nervous system injury  
 
A focal injury of the adult mammalian brain leads to a number of temporally ordered 
reactive responses in neurons and glial cells in the affected areas. The affected brain areas 
are (1) the directly damaged regions, (2) the regions that are in the close vininity of the 
injury, (3) the axotomised regions in which retrograde degeneration takes place, and (4) the 
denervated regions lacking input (Fig. 1). The temporally ordered cellular responses 
triggered by the lesion are (a) neuronal cell death, (b) sequential activation of microglial 
cells and astrocytes, (c) transneuronal degeneration processes, and (d) lesion-induced 
sprouting of uninjured neurons in distal target areas of the axotomized neurons (Raisman, 
1969; Steward, 1989; Steward et al., 1993; Kelley and Steward, 1997; Hirsch and Bahr, 
1999).  
 
 
 
 
Figure 1 Schematic illustration: Effects of a CNS lesion on the neuronal network 
 
A lesion of the CNS affects the neuronal network: Cell A is axotomized (the cross indicates the 
directly damaged region). Terminals of cell A degenerate (dashed line), and cell B loses its input 
from cell A. Cell C is not directly damaged by the lesion, but terminates in the vicinity of degenerating terminals. Cell D is a target neuron of cell B and may be affected transneuronally if 
cell B dies or atrophies (Deller and Frotscher, 1997).  The context of the present work is the regulation of the lesion-induced sprouting of 
uninjured neurons in a target area lacking input. A candidate molecule, the 
chondroitinsulfate proteoglycan (CSPG) NG2, was investigated in a time course analysis in 
the denervated outer molecular layer (OML) of the rat dentate gyrus, in order to ascertain 
wether NG2 may contribute to the regulation of the lesion-induced sprouting response in 
injured adult rat brain.  
 
 
Axonal sprouting after entorhinal cortex lesion  
 
The phenomenon of lesion-induced sprouting can be well studied using the entorhinal 
cortex lesion (ECL) model (Lynch et al., 1972; Del Turco et al., 2003). In this lesion model 
the fibers of the Tractus perforans are transected electrolytically. The transected fibers 
originated from stellate neurons of layer II in the entorhinal cortex (EC) and terminate 
mainly in the ipsi- and contralateral outer molecular layer (OML) of the dentate gyrus, 
where they contact distal dendrites of the granule cells from the granule cell layer (Steward 
and Scoville, 1976; Deller et al., 1996b). Additionally, fibers from the EC terminate in 
stratum lacunosum-moleculare of hippocampal subfields CA1-CA3. The transection of the 
Tractus perforans leads to several degeneration processes and results in the denervation of 
the OML. The denervation is followed by collateral sprouting of un-injured fibers that 
terminate also in the denervated layer, e.g. fibers from the contralateral EC and from the 
medial septum, thereby reinnervating the denervated OML (Lynch et al., 1976). 
Remarkably, the collateral sprouting of the un-injured fibers is strictly layer-specific 
(Frotscher et al., 1997). Only those fibers reinnervate the OML that terminate in the 
denervated zone already before lesioning. Fibers from the adjacent inner molecular layer 
(IML) do not invade the denervated zone (Fig. 2). Therefore, the laminar organization of 
the dentate gyrus is maintained following lesion of the entorhinal cortex (Deller et al., 
2001).   
 
Figure 2 Schematic illustration: The entorhinal cortex lesion model (Deller, 1998)  
 
a.  Topography of the entorhino-hippocampal projection. Fibers of the EC project to 
the hippocampus (H) in a topographically ordered, lamina-specific manner. 
b.  Horizontal section of the hippocampal formation. Neurons located in layer II of the 
EC form the perforant pathway projecting to the OML of the DG. Additionally, fibers from 
the EC project to stratum lacunosum-moleculare of CA1-CA3. The red line indicates the 
site where the perforant pathway is transected. 
c.  Lamina-specific termination and sprouting of afferent fibers in the DG. A typical 
granule cell is illustrated. On the right hand side the major afferent fiber systems are 
indicated. The size of the lettering indicates the relative contribution of these fibers to the 
innervation of the DG. Following ECL, the entorhinal input is lost. The remaining fiber 
systems sprout and reinnervate the DG in a layer-specific fashion. The green fiber indicates 
sprouting afferents that reinnervate the OML following denervation. Fibers that terminate 
in the non-denervated adjacent IML (blue fiber) do not invade the denervated zone.  
CA1, CA3: hippocampal subfields, DG: dentate gyrus, EC: entorhinal cortex, ECL: 
entorhinal cortex lesion, GCL: granule cell layer; H: Hippocampus, IML: inner molecular 
layer, OML: outer molecular layer ECL is a well established lesion model to investigate the regulation of sprouting 
mechanisms in injured brain (Lynch et al., 1972; Cotman et al., 1973; Matthews et al., 
1976; Steward, 1976). Two of its advantages are:  
 
1.) The lengthy distance between the lesion site and the denervated OML. This allows an 
investigator to discriminate between lesion-induced neurodegenerative processes (e.g. local 
damage and glial scar formation at the entorhinal cortex) and lesion-induced reactive 
processes occuring in the denervated area (OML). The lesion-induced reactive processes 
are the initial degeneration of entorhinal fibers, followed by a local reaction of glial cells 
and sprouting of surviving fibers that contribute to the reinnervation of the denervated 
dentate gyrus. 
 
2.) The layer-specific termination of the Tractus perforans in the OML. This layer-specific 
termination of entorhinal fibers allows an investigator to differentiate between sprouting 
fibers terminating within the denervated OML and those fibers originating  from non-
denervated adjacent layers, e.g the IML (Deller et al., 1995a; Deller et al., 1996a).  
 
The phenomenon of layer-specific collateral sprouting in the dentate gyrus following ECL 
led to the question which cells and molecules could be involved or even regulate the 
reinnervation process (Steward, 1995; Savaskan and Nitsch, 2001; Deller et al., 2001). As 
fas as the molecular regulation of the sprouting response is concerned, it has been 
hypothesized that at least two groups of molecules play a major role: (a) molecules that are 
intrinsic to the sprouting cell, the so-called “intrinsic” molecules, and (b) molecules of the 
environment of the sprouting cell, the so-called “extrinsic” molecules (Fawcett, 1997; 
Frotscher et al., 1997; Deller et al., 1997; Deller et al., 1999). 
 
 
Molecular regulation of sprouting 
 
Intrinsic molecular cues are expressed by growing neurons themselves (e.g. during 
development) and determine their growth capacity (Caroni, 1997; Benowitz and 
Routtenberg, 1997). Molecules that may regulate the growth response of sprouting fibers 
following ECL are e.g. the growth associated protein GAP43, or CAP23 (Benowitz et al., 
1990; Masliah et al., 1991; Fawcett, 1992).  Extrinsic molecular cues reside in the microenvironment of growing axons (Rauch, 1997). 
Extrinsic molecules are found in the vicinity and in the target area of growing axons where 
they are important for neuronal pattern formation (Faissner, 1993; Rauch and Schafer, 
2003). These molecules may guide growing axons not only to the correct target region but 
also to the correct target cell (Rauch, 1997; Margolis and Margolis, 1997). They regulate 
the degree of axonal branching, the number of synapses that are formed and they may play 
a role in synaptic stabilization (Faissner et al., 1994; Faissner and Steindler, 1995; Rauch, 
2004). Extrinsic molecules that may be involved in the regulation of lesion-induced 
changes in the dentate gyrus are cell adhesion molecules (e.g. N-CAM), diffusible 
molecules (e.g. growth factors and cytokines), and extracellular matrix (ECM) molecules 
(e.g. tenascin-C, Neurocan). All of these molecules can be produced either by nerve or by 
glial cells within the target region (Fig. 3). The various regulatory molecules are 
subdivided into those stimulating axonal growth and those inhibiting axonal growth 
(Goodman, 1996; Tessier-Lavigne and Goodman, 1996; Bovolenta and Fernaud-Espinosa, 
2000). Within the group of ECM molecules that might regulate lesion-induced sprouting 
after ECL, some members of the family of chondroitin sulfate proteoglycans (CSPGs) 
were found (Haas et al., 1999; Thon et al., 2000; Deller et al., 2001; Savaskan and Nitsch, 
2001).  
 
Figure 3 Schematic illustration: Molecular regulation of sprouting. Modified from (Deller 
and Frotscher, 1997) 
1.    Intrinsic molecules determine the growth capacity of uninjured nerve cells (N) 
sprouting and reinnervating the target cell (T).  
2.  The extrinsic molecules reside in the vicinity of sprouting axons. They may be 
involved in the regulation of sprouting axons and can be produced by glial cells (G).  Chondroitinsulfate proteoglycans (CSPGs) 
 
Molecules of the CSPG family are functionally versatile and are known to be involved in a 
large number of biological processes during development of the zentral nervous system 
(Miller et al., 1995; Margolis and Margolis, 1997) as well as in the adult brain (Rauch et 
al., 1991; Snow and Letourneau, 1992; Grumet et al., 1996). Although some CSPGs have 
growth promoting effects on growing axons (Faissner et al., 1994; Anderson et al., 1998) 
most CSPG species inhibit axonal growth. Since CSPGs were enriched at lesion sites 
following brain injury, it has widely been assumed that they contribute to the regeneration 
failure of axons within the CNS (Fawcett and Asher, 1999; Asher et al., 2001; Morgenstern 
et al., 2002; Rhodes et al., 2003).  
 
 
A member of the CSPG family: NG2 
 
A prominent member of the CSPG family is NG2 (Fig. 4). This CSPG was first described 
as a cell surface molecule expressed by immature neural cells by Wilson and coworkers 
(Wilson et al., 1981). The full-length NG2 is a transmembrane CSPG integral membrane 
protein consisting of three domains: a large extracellular region with three 
glycosaminoglycan side chains, a single transmembrane domain, and a short cytoplasmatic 
tail (Nishiyama et al., 1991; Levine and Nishiyama, 1996; Stallcup, 2002). NG2, which is 
not specific to nervous tissue, is present on the surface of multipotent glial precursor cells 
during brain development (Levine and Stallcup, 1987; Levine et al., 1993). Furthermore, 
NG2 is expressed by a subset of glia in the mature brain (Levine and Nishiyama, 1996), 
and expressed by glia and macrophages in the vicinity of an injury (Levine, 1994; Jones et 
al., 2002; Jones et al., 2003). NG2 binds to type V and VI collagen and to other ligands, 
such as the platelet-derived growth factor-alpha receptor (Tillet et al., 1997; Levine and 
Nishiyama, 1996; Sandvig et al., 2004).  
Different cell lines express different forms of the NG2 core protein. Many of the cell lines 
express the full length 300kDa core protein, lacking the cytoplasmatic domain but contain 
almost the entire ectodomain and release a 290kDa form into the medium. There also exist 
cell lines that express a truncated 275 kDa core protein form, lacking the cytoplasmatic 
domain and at least 64 amino acids of the ectodomain (Nishiyama et al., 1995).  
 In vitro studies have documented a considerable axon growth-inhibitory potential of the 
full-length NG2 proteoglycan and of the core protein of NG2, that is obtained by 
enzymatic removal of the chondroitin sulfate side chains. The chondroitinase treatment 
indicated that the inhibitory potential of NG2 was mediated by the core protein rather than 
through the glycosaminoglycan chains (Dou and Levine, 1994; Fidler et al., 1999; Ughrin 
et al., 2003). Additionally, several in vivo studies showed an enrichment of NG2 in the 
glial scar following CNS injury (Fawcett and Asher, 1999; Chen et al., 2002a; Camand et 
al., 2004; Rezajooi et al., 2004). Although a glial scar does not form in the denervated 
OML following ECL, all glial cells in the OML strongly react to denervation. Micro- and 
astroglia glial cells phagocytose degenerating axons and their terminals (e.g., Rose et al., 
1976; Gall et al., 1979; Bechmann and Nitsch, 1997; Deller et al., 1999; Jensen et al., 
1999; 2000; Bechmann and Nitsch, 2000; Drojdahl et al., 2004). Reactive astrocytes are 
believed to regulate the axonal sprouting response by altering the composition of the 
extracellular matrix (e.g., Deller et al., 1997; 2000; 2001; Haas et al., 1999; Thon et al., 
2000) and produce most of the CSPGs in the denervated OML (Savaskan et al., 2000b; 
Deller et al., 2001; Thon et al., 2000).  
The definite cell type producing NG2 in the nervous system is still under debate (Bu et al., 
2001; Jones et al., 2002; Chekenya et al., 2002; Greenwood and Butt, 2003; Peters and 
Sethares, 2004a; Belachew et al., 2003; Butt et al., 2002) and even less is known about the 
cell type producing NG2 in the denervated OML after ECL. 
 
 
  Figure 4 Schematic illustration: Drawing of NG2 (Levine and 
Nishiyama, 1996)  
 
“The double lines represent the plasma membrane, the jagged 
lines the chondroitin sulfate glycosaminoglycan chains, -S-S- 
represents disulfide bonds, the arrowhead denotes the site of 
proteolytic cleavage that generates the 275 kDa fragment of the 
core protein, and the arrow denotes a cleavage site that generates 
the 290kDa fragment. The position of threonine 
2255 is indicated 
and the dotted line represents the sites of potential intramolecular 
interactions that retain the association of the 275 kDa fragment 
with the cytoplasmic domain of the core protein. The position of 
the 1657 peptide is indicated with a solid block.” Concerning the regulation of layer-specific sprouting in the denervated OML, the glia-
derived CSPG NG2 is of interest for several reasons: 
 
1.) NG2 strongly inhibits axonal growth. NG2 has been implicated in the regulation of 
axonal growth and axonal regeneration following injury of the spinal cord (Fidler et al., 
1999; Levine et al., 2001; Jones et al., 2002). In the spinal cord it is thought to inhibit 
axonal regeneration across the glial scar. This regulatory role of NG2 under conditions of 
CNS injury suggests that NG2 could also regulate axonal growth processes in denervated 
areas of the brain.  
Therefore, the working hypothesis is that NG2 is also involved in the regulation of the 
layer-specific sprouting response of uninjured fibers in the denervated OML.  
 
2.) Processing of NG2 could change the composition of the ECM in the denervated OML. 
In vitro and at the glial scar NG2 can be cleaved by metalloproteases at its membrane 
domain (Nishiyama et al., 1995; Larsen et al., 2003). Whether or not processing of NG2 
occurs in denervated brain areas is unknown. Since cleaved NG2 could chance the 
composition of the ECM it may play a regulatory role for the sprouting response of 
growing axons following ECL.  
 
3.) The identity of NG2 producing cells in denervated areas of the brain is unknown. If 
NG2 is involved in layer-specific reorganisation processes following ECL it may be 
interesting to know by which cell type this CSPG is produced.  
 
 
Aims of the study  
 
The experiments reported here were designed to gain insight into the molecular regulation 
of the layer-specific collateral sprouting response following ECL. To study wether the 
CSPG NG2 could be involved in the reorganisation processes in the rat fascia dentata, 
changes in NG2 were analyzed following ECL and correlated with the sprouting response. 
In detail, the following questions were investigated using the indicated methods:  
 
1.) To study wether NG2 is expressed in denervated areas of the brain, the ECL model was 
used. 2.) To elucidate the time course of changes in amount of NG2 mRNA expression of the 
denervated OML, lasermicrodissection (LMD) was combined with subsequent quantitative 
reverse transcription PCR (qPCR). 
 
3.) To elucidate the time course of NG2 protein changes, immunohistochemical methods 
were used.  
 
Both, amount of NG2 mRNA and protein in the denervated fascia dentata were 
investigated in a time course analysis and correlated with the postlesional sprouting 
response.  
 
4.) To verify wether NG2 is secreted into the ECM of the denervated OML, electron 
microscopy was used. 
 
5.) To identify the NG2-expressing cell type, double-labelings of NG2-positive cells with 
markers for astrocytes, microglia/macrophages, and mature oligodendrocytes were 
performed before and after entorhinal deafferentation.  
 
6.) To determine wether or not some NG2-positive cells were generated post lesion, 
double-labeling of NG2-positive cells with 5´-bromo-2´-deoxyuridine (BrdU) for 
generated cells was performed after ECL.  
 Materials and Methods 
 
 
Animals, surgical procedures, and tissue preparation 
 
Animals 
 
A total of seventy adult male Sprague Dawley rats (250-350g; Charles River Wiga, 
Sulzfeld, Germany) housed under standard laboratory conditions were used in this study. 
For light microscopy, control rats (n=4), and EC-lesioned rats surviving for 1 day (d), 4d, 
7d, 10d, 14d, 30d, and 6 months post lesion were employed (n=4 for each time point). For 
electron microscopy, EC-lesioned rats surviving for 10d (n=2) were used. For LMD and 
qPCR, control rats (n=4), and EC-lesioned rats surviving for 6 hours (h), 12h, 2d, 4d, and 
7d post lesion were used (n=4 for each time point). For BrdU-labeling, EC-lesioned rats 
surviving for 10d (n=2), and control rats (n=2) were used. 
 
 
Entorhinal cortex lesion 
 
All surgical procedures were performed under deep pentobarbital-sodium anaesthesia 
(50mg/kg body weight Narcoren, Merial GmbH, Hallbergmoos, Germany) in agreement 
with the German law on the use of laboratory animals. For lesioning of the entorhinal 
cortex, the head of the animal was horizontally aligned in a stereotaxic frame (Kopf 
Instruments, Tunjunga, USA). Using sterile procedures, the skin was retracted and a hole 
was drilled above the lesion site without disruption of the underlying dura using a handheld 
dental drill (Proxxon Micromot 50, Hickory NC, USA; drill heat: Dremel 107, 
Leinenfelden-Echterdingen, Germany). A standard electrocoagulator (Erbe, Tübingen, 
Germany) was used to perform a complete unilateral electrolytic lesion (3 single pulses, 
2.0µA, 1s each). One cut was placed in the frontal plane and one cut was placed in the 
sagittal plane between the entorhinal area and the hippocampus. The two electrolytic cuts 
result in a complete destruction of the ipsilateral afferents from the entorhinal cortex to the 
fascia dentata (Deller et al., 1995a; Deller et al., 1996a; Deller et al., 1996c). The following 
coordinates measured from the interaural line were used: frontal cut: AP +1, L +3 to +7, V down to the base of the skull; sagittal cut: AP +1 to +4, L +6.7, V down to the base of the 
skull (Paxinos and Watson, 1982). Finally, the head wound was closed and the animal was 
carefully returned to cage. For postoperative analgesia metamizol-sodium analgetica was 
added to the drinking water (0.1% Novaminsulfon, Ratiopharm Merckle GmbH, 
Blaubeuren, Germany).  
 
 
Tissue preparation 
 
Rats were deeply anesthetized with an overdose of pentobarbital-sodium anaesthesia 
(300mg/kg body weight, Merckle) and for immunohistochemistry transcardially perfused 
with 0.9% NaCl followed by 4% paraformaldehyde in 0,1M phosphate buffered saline 
(PBS, pH: 7.4). Brains were removed and post-fixed for 24h in the same fixative. For 
electron microscopy 0.1% glutaraldehyde was added. Serial frontal or horizontal sections 
(50µm) were cut with a vibratome (VT 1000S, Leica, Bensheim, Germany). 
 
For LMD and qPCR, rats were anaesthetised using an overdose injection of pentobarbital-
sodium anaesthesia (300mg/kg body weight, Merckle). Brains were removed, embedded in 
tissue freezing medium (Leica) and immediately flash-frozen in 2-methyl-butane at –40°C 
(5min) for short-term storage at –70°C or for instant sectioning. Serial cryostat sections 
(20µm) of the septal portion of the hippocampus were cut (Leica CM 3050S, Leica) and 
mounted on autoclaved polyethylene terephthalate- (PET-) foil stretched on a metal frame 
(Leica). Sections were then fixed in ice-cold acetone for 3min, dried on a heater at 40°C 
for 5min, and subjected to LMD and qPCR. Using LMD three microdissected OML per 
animal were collected and pooled for qPCR analysis.  
 
 
Control of lesion quality  
 
The quality of the entorhinal cortex lesion is critical for this study. Only animals with a 
complete entorhinal cortex lesion and without damage of the dentate gyrus were used for 
further analysis. Both, the completeness of the lesion and the intactness of the dentate 
gyrus were scrutinized in three steps: 
 1.) Rat brains were checked visually after perfusion and dissection. Only those animals 
were used for further analysis (horizontal sectioning) which did not show an unusually 
large hemorrhage within the first 10d after lesion. At later time-points (14d, 30d, and 6 
month), a small and filiform glial scar had to be existent at the lesion site.  
 
2.) The completeness of the ECL was verified in each animal macroscopically by 
sectioning (50µm) the lesion site horizontally on a vibratome (VT 1000S, Leica). Only 
those animals were used for further analysis (staining of transversal sections) which had 
received a complete perforant pathway transection, and which did not show any damage to 
the dentate gyrus. For a complete perforant pathway transection, the two unilateral 
electrolytic cuts had to be placed in the frontal and in the sagittal plane between the 
entorhinal area and the dentate gyrus.  
 
3.) The completeness of the ECL was verified histochemically using frontal sections of 
lesioned rat hippocampus. For animals perfused at 1d, 4d, and 7d post lesion, the Fluoro-
Jade B procedure was used. This procedure labels degenerating axons and their terminals 
with the anionic fluorescein derivative Fluoro-Jade B, and can be employed to detect 
axonal degeneration in the OML (Anderson et al., 2005; Schmued and Hopkins, 2000; 
Savaskan et al., 2000a). For animals surviving 10d, 14d, 30d, and 6 months, the classical 
acetylcholinesterase (AChE) procedure, which labels cholinergic fibers, was used to verify 
lesion completeness (Lynch et al., 1972; Zimmer et al., 1986). Both procedures have been 
used to demonstrate lesion quality after ECL in rats. The stainings indicate the extent of 
axonal denervation (Fluoro-Jade B procedure) and reinnervation (AChE histochemistry) 
following ECL. An enhanced staining in the OML indicates degenerated or sprouted 
axons, respectively. Every tenth section was processed for the Fluoro-Jade B procedure or 
AChE histochemistry. Only those animals were included in the study that showed 
increased Fluoro-Jade B staining or the typical AChE band in the OML (Fig. 5 b, d).  
 
 
Fluoro-Jade B procedure 
 
Transversal sections were mounted on slides and dried overnight (RT). Then, sections were 
incubated in a solution of 1% NaOH in 80% Ethanol (5min), hydrated in graded Ethanol 
and distilled water (70%, 50%, each: 2min) before incubating in a 0.06% potassium permanganate solution (8min). After rinsing in distilled water (2min), sections were 
incubated (20min) in a 0.0004% solution of Fluoro-Jade B (Histo-Chem Inc. Jefferson, Ar, 
USA). Finally, sections were rinsed thoroughly in distilled water (4 x 2min), dried on a 
slide warmer (10min), and coverslipped with anti-fading fluorescent mounting medium 
(DAKO
©   Fluorescent Mounting Medium, Dako, Hamburg, Germany). Sections were 
photographed by an attached Spot2 digital camera (Diagnostics Instruments, Sterling 
Heights, MI, USA) on a Fluorescent Microscope (Olympus BX-40, Color View, Hamburg, 
Germany). 
 
 
AChE procedure  
 
Frontal sections were mounted onto slides and dried overnight. Then, sections were rinsed 
in 0.1M maleic buffer (2 x 4min), and incubated (2h) in 0.1M maleic buffered 
acetylcholine iodide incubation solution. After rinsing in 0.1M Tris buffered saline (TBS, 
ph 7.6, 3 x 4min), sections were incubated (10min) in Tris buffered 0.5% cobalt chloride 
and rinsed again in TBS (3 x 4min). The labeling was visualised with a nickel/DAB 
solution (0.005% 3,3`-diaminobenzidine, 0.005% nickel-ammonium sulfate, 0.006% cobalt 
chloride, 0.001% H2O2 in 0.1M PB), which resulted in a deep-blue labeling of the 
cholinergic neurons. The reaction was stopped by rinsing the sections in TBS. Finally, 
sections were dehydrated in graded Ethanol and Toluol (70%, 80%, 95%, 100%, 100%), 
and coverslipped with Hyper-Mount
TM (Shandon Inc. Pittsburgh, PA, USA).  
 
Incubation solution for AChE histochemistry 
 
The Maleic buffered acetylcholine iodide incubation solution (0.1M, pH 8.0) contains: 
360ml    maelic buffer (1.96% di-Sodiummaleate dihydrate) 
40ml     H2O 
0.003g   Promethazine Hydrochloride (Sigma, Taufkirchen, Germany) 
0.56g     di-Sodium Maleate 2-hydrate (Merck, Darmstadt, Germany) 
0.059g   tri-Sodium Citrate 2-hydrate (Roth, Karlsruhe, Germany) 
0.03g     Cupric (II) Sulfate 5-hydrate (AppliChem) 
0.006g   Potassiumferricyanide (Merck) 
0.021g   Acetylcholine Iodide (Sigma)  Fluoro-Jade B and AChE staining on frontal sections of rat dentate gyrus  
 
 
 
 
 
Figure 5 Fluoro-Jade B and acetylcholinesterase histochemistry reveal the extent of axonal denervation and 
reinnervation following entorhinal cortex lesion 
 
a, b.  Fascia dentata of a control animal (a) and an animal 4d after ECL (b) stained for Fluoro-Jade B. 
Note the enhanced fluorescent Fluoro-Jade B labeling in the denervated OML of the lesioned animal. 
c,  d.  Control animal (c) and an animal 30d after ECL (d). In the lesioned animal, a dense 
acetylcholinesterase-positive fiber band is present in the OML. Note the sharp border (arrows) between the 
OML and the non-denervated IML. Scale bars: a:100µm, b-d: 150µm. 
CA3: hippocampal subfield CA3, ECL: entorhinal cortex lesion, GCL: granule cell layer, H: hilus, IML: 
inner molecular layer, ML molecular layer, OML: outer molecular layer  Combined lasermicrodissection (LMD) and quantitative RT-PCR (qPCR) 
 
Laser microdissection (LMD) is a research tool, which allows the isolation of specific 
tissue from a section of complex, heterogeneous tissue under direct microscopic 
visualisation. The combination of LMD with qPCR is a highly sensitive technique for 
studying gene expression, particularly in tissue where low expression changes are 
suspected that may otherwise escape detection (Ando et al., 2003; Prosniak et al., 2003). In 
this project, an optimized protocol of combined LMD/qPCR for microdissecting cell layers 
in the rat CNS was used (Burbach et al., 2004; Burbach et al., 2003). The Leica AS LMD 
system (Leica Microsystems, Wetzlar, Germany) was used to microdissect the OML of 
frontal brain sections. Subsequently, the Abi Prism 7000 Sequence Detection System 
(Applied Biosystems) was used to quantify the amount of NG2 mRNA in the 
microdissected tissue piece (Fig. 6).  
 
  
Flow chart of the combined LMD and qPCR protocol 
 
 
 
 
 
Figure 6 Flow chart showing the important steps of the combined lasermicrodissection 
with subsequent qPCR protocol. Modified from Burbach (Burbach et al., 2003) First, transversal brain sections were stained at room temperature (RT, 1min) with a 1% 
toluidine blue solution (Merck, Darmstadt, Germany) dissolved in RNAse-free DEPC-
treated water which was filtered through a 0.22µm Millex
TM GP filter (Millipore, 
Eschborn, Germany). Then, the sections were briefly rinsed in DEPC water. After 
differentiation in 75% ethanol in DEPC (3min), sections were dried on a heater at 40
0C 
(5min) and immediately subjected to LMD. The PET-foil frames were mounted on a Leica 
AS LMD system with the section facing downwards. After adjusting intensity, aperture, 
and cutting velocity, the pulsed UV laser beam was directed along the border of the OML. 
Under direct microscopic visualisation the area of the infrapyramidal OML was dissected 
(Fig. 6). Using a 20x objective, settings were as follows: aperture 10, intensity 45, speed 6, 
and offset 39.  
 
The microdissected tissue was transferred by gravity alone into a microcentrifuge tube cap 
placed directly underneath the section. Per animal three microdissected OML were 
collected. The tube cap was filled with a guanidine isothiocyanate (GITC) containing 
buffer (Buffer RLT, RNeasy Mini Kit, Qiagen, Hilden, Germany) to ensure isolation of 
intact RNA. Tissue collection was verified by inspecting the tube cap at higher 
magnification. Microcentrifuge tubes were immediately transferred on ice after tissue 
collection followed by three freeze-thaw cycles in a dry-ice/ethanol bath .  
 
 
Protocol for RNA isolation using the LMD and RNeasy
® Micro Kit 
(Quiagen)/TaqMan Reverse Transcription Reagents (Applied Biosystems) 
 
Total RNA was isolated using the RNeasy
® Mikro Kit (50) (Qiagen) according to the 
manufacturer's recommendations including on-columm (RNeasy MinElute™ Spin 
Column, Quiagen) DNAse treatment and a 2 x 30µl elution step. Finally, RNA was reverse 
transcribed using TaqMan Reverse Transcription Reagents (Applied Biosystems, 
Darmstadt, Germany).  
 
RNeasy
® Micro Kit (50) contains: 
 
Rneasy MinElute™ Spin Columns in collection tubes 
Collection tubes (1.5ml, 2ml) Buffer RLT (contains guanidine isothiocyanate, GITC) 
Buffer RW1 (contains ethanol) 
Buffer RPE (supplied as concentrate, before usage adding 100% ethanol) 
RNAse free water (bottle and tube) 
Buffer RDD (completely unknown composition) 
RNase free DNase 
Carrier RNA, poly-A 
 
 
The mastermix for the reverse transcription reaction using 30µl solution of isolated RNA 
using TaqMan Reverse Transcriptase Reagents (Applied Biosystems) contains:  
 
7.5µl    10 x RT buffer 
16.5µl   MgCl2 
15µl   dNTP 
3.75µl   Random Hex. 
1.5µl   RNase  inhibitor 
1.875µl  Reverse Transcriptase  
 
 
Following is the detailed protocol developed for RNA isolation using the LMD and 
RNeasy
® Micro Kit (50), inclusive DNase digestion and reverse transcriptase reaction 
using TaqMan Reverse Transcription Reagents (Applied Biosystems, Darmstadt, 
Germany). The protocol bases on manufacturer's recommendations. However, it was 
developed specifically for rat brain material. 
 
1.  Pipet (Eppendorf Pipet, Eppendorf, Wesseling-Berzdorf, Germany )  
30µl RLT Buffer (with 1% β-mercaptoethanol, AppliChem) in the cap of a 
microtube. 
2.  Lasermicrodissect the tissue and collect the tissue piece in the microtube cap 
3.  Transfer the probe immediately on ice 
4.  Spin down (Centrifuge 5417 R, Eppendorf) 
5.  Freeze-thaw the probe 3 times in dry ice / ethanol bath 
6.  Add the probe in 320ml RLT buffer and mix it carefully by up-down pipeting 7.  Add lysate on column, spin down (20sec, 10000 revolutions per minute (rpm), 
RT), and trash discharge 
8.  Add 350µl RW1 buffer on column, spin down (15sec, 10000rpm, RT), and 
trash discharge 
9.  Mix 10µl DNaseI (dissolved in 550µl RNase free water) and 70µl RDD buffer 
very carefully by swivel the tube 
10.  Add the DNaseI solution on column incubating for 20min (RT) 
11.  Add 350µl RW1 buffer on column, spin down (15sec, 10000rpm, RT), and 
trash discharge 
12.  Put the column in a new tube, add 500µl RPE buffer, spin down (20sec, 
10000rpm, RT), and trash discharge 
13.  Add 500µl RPE buffer, spin down (2min, 10000rpm, RT), trash discharge, and 
spin again (1min, 14000rpm, RT)  
14.  Put the column in a new tube, add 30µl RNase free water incubating for 5min 
(RT), and spin down (1min, 12000rpm, RT) 
15.  Put the discharge on the column, and spin down (1min, 12000rpm, RT) 
16.  Add 46.125µl mastermix to the 30µl discharge for the reverse transcriptase 
reaction and mix it carefully. 
17.  Reverse transcriptase reaction occurs during incubation for 10min at RT, and 1h 
at 48
0C (Thermomixer Compact, Eppendorf). 
18.  Finish procedure with heating 5min at 95
0C (Thermomixer Compact, 
Eppendorf), immediatly freezing on ice, and a final down spin. 
 
 
Quantitative reverse transcription-PCR (qPCR) 
 
CDNAs were subjected to qPCR utilizing the Abi Prism 7000 Sequence Detection System 
(Applied Biosystems) and TaqMan Universal PCR Master Mix (Applied Biosystems). 
NG2 primers and an intron-spanning probe bridging the border between Exon 6 and Exon 
7 of the NG2 gene were selected using the Primer Express software (Applied Biosystems). 
This ensured the specific detection of rat NG2 mRNA without amplification of genomic 
DNA. This region corresponds to the extracellular tail of the mature NG2 protein. For 
normalization of CT-values to an endogenous control, eukaryotic 18S ribosomal RNA 
primers and probe were used. The probes were labeled with 6-carboxyflurescein (FAM) at the 3`end and with 6-carbox-tetramethyl-rhodamine (TAMRA) at the 5`end. The following 
rat-specific primers were used: NG2: 5`-TGG ACA GCG GGC TTG TG-3` (sense), 5`-
CGC CAT CAG AGA GGT CGA A-3` (antisense), 5`-TTC TCA CAG AGA GGA GCC 
CTG GAA GG-3` (probe). 18S: 5’-CGG CTA CCA CAT CCA AGG AA-3’ (sense), 5’-
GCT GGA ATT ACC GCG GCT-3` (antisense), 5`-TGC TGG CAC CAG ACT TGC CCT 
C-3` (probe).  
 
For amplification of target sequences, a standard amplification program was used: 1 cycle 
of 50
0C/2min, 1 cycle of 95
0C/10min, 45 cycles of 95
0C/15sec, and one cycle of 
60
0C/1min Then, a relative quantitation of target cDNA expressed in relative x-fold 
differences was performed. All quantifications were normalized to the endogenous control 
(18S rRNA) to account for variability in the initial concentration and in the conversion 
efficiency of the reverse transcription reaction. For relative quantification of NG2 mRNA 
expression following ECL, the NG2 mRNA level measured in the OML of non-lesioned 
control animals was set as reference level (equivalent: one). NG2 mRNA levels measured 
in lesioned animals were expressed as x-fold changes compared to the reference (control) 
level.  
 
Statistical analysis was performed using SPSS for Windows (SPSS, München, Germany). 
The non-parametric Kruskal-Wallis-test was used to compare differences among the 
groups investigated and pair-wise analysis was performed using the Mann Whitney U-test. 
Differences were considered statistically significant if the p-value was p ≤ 0.05. 
 
 
Immunohistochemistry 
 
In this study, standard immunohistochemical procedures were employed. These involved: 
(1) specific antigen binding by a primary antibody, (2) binding of a secondary antibody, 
either a fluorocrome conjugated or a biotin-conjugated antibody to the tissue bound 
antibody-antigen complex, and finally (3) detection of the tissue bound biotin using the 
well established avidin-biotin-peroxidase system, and Diaminobenzidine (DAB) as a 
chromogen (Hsu et al., 1981). 
Optimal conditions for the immunohistochemical detection were determined for each 
individual antibody. Conditions depended on antigen availability, antigen antibody affinity, antibody type, and detection enhancement method. The working dilutions for the 
antibodies were optimized for each system in which they were employed. The working 
dilution was considered optimal if a strong specific antigen staining and a weak non-
specific background, i.e. a good signal-to-noise ratio, was obtained.  
 
 
Staining protocols 
 
For light microscopy, free-floating sections were washed in phosphate buffered saline 
(PBS) and incubated in PBS containing 10% methanol and 3% hydrogen peroxide (H2O2) 
for 0.5h to reduce endogenous peroxidase activity. Then, the sections were washed (3 x 
4min) and incubated in 5% bovine serum albumin (BSA, 1h) to reduce the unspecific 
staining. Subsequently, the sections were incubated for two days at 4°C in the primary 
antibody solution (polyclonal rabbit anti-NG2, 1:1000 in 0.1M PBS, containing 1% BSA, 
Chemicon, Temecula, USA). For the immunohistochemical detection of the primary 
antibody, a secondary biotinylated antibody was used (1:200, RT, biotinylated anti-rabbit; 
Vector Laboratories, Burlingame, USA). Then, sections were washed (3 x 4min)and 
transferred to ABC solution (ABC-Elite, Vector Laboratories) for 2h. After washing the 
sections in PBS, they were stained with a solution containing 0.0025% DAB, 0.005% 
ammonium-nickel-sulphate, and 0.006% cobalt-chloride activated with 0.001% H2O2. 
Finally, the sections were mounted onto slides, dehydrated through an ascending ethanol 
series, and coverslipped. Sections were digitally photographed (Olympus BX-61).  
 
Double-immunofluorescence was employed for further characterization of NG2-positive 
cells. Free-floating sections were washed in PBS (3 x 4min), incubated in 5% BSA (1h) to 
reduce unspecific staining. Subsequently, they were incubated in either anti-NG2 mouse or 
rabbit antiserum (1:1000, 1% BSA, 4°C, 2d, Chemicon), depending on the species in 
which the second antiserum for the second marker was generated. After washings in PBS 
(3 x 4min), sections were incubated with an Alexa 568-labeled goat anti-rabbit or anti-
mouse secondary antibody (1:1000, 1% BSA, RT, 2h, Molecular Probes, Eugene, USA). 
Then, sections were incubated (24h, 4°C) with the following glial markers:  
 
1.)  The astrocyte marker mouse anti-glial fibrillary acidic protein (GFAP, 1:1000, 
Sigma-Aldrich, Taufkirchen, Germany), or the astrocyte marker mouse anti-S100 Beta (1:1000, Sigma) which is a marker for the calcium binding protein found in 
the cell bodies of astrocytes. 
 
2.)  The microglia/macrophage marker rabbit anti-ionised calcium binding adapter 
molecule 1 (IBA1, 1:1000, 1% BSA, Wako Chemicals, Neuss, Germany). 
 
3.)  With the adult oligodendrocyte marker mouse anti-myelin phospholipid protein 
(PLP, 1:1000, Serotec, Kidlington, UK) or with the oligodendrocyte precursor 
marker, rabbit anti-platelet-derived-growth factor-receptor-α (PDGFR-α, 1:1000, 
Abcam, Cambridge, UK) 
 
After washing (0.1M PBS, 3 x 4min), sections were incubated (2h, RT) with an Alexa 488 
labeled goat anti-rabbit (for IBA1) or a goat anti-mouse antibody (for PLP and GFAP). 
Finally, sections were washed (3 x 4min), transferred onto glass slides, and mounted under 
glass coverslips with anti-fading fluorescent mounting medium (DAKO
©, Dako). Double-
labelled sections were analysed with a Zeiss LSM 510 laser scanning microscope (Zeiss, 
Jena, Germany) using a Zeiss 20 x lens (NA 0.75) and 7 x digital zoom. 
 
For immunohistochemical detection of BrdU-labeled cell nuclei, free floating sections 
were preincubated in 15% methanol and 3% H2O2 (30min) followed by washing in PBS (3 
x 7min). DNA was denatured to expose the antigen by incubation in 2x sodium saline 
citrate (SSC, 0,3M NaCl and 0,03M sodium citrate, ) for 15min at RT, then for 5min at 
60°C, followed by incubation in 2N HCl for 30min at 37°C. Acid was neutralized in 0,1M 
borate buffer (pH 8.5, 10min) and washed in PBS (3 x 7min). The sections were blocked 
with 10% goat serum and 10% bovine serum albumin in PBS (1h). Then, sections were 
incubated for double-labeling with mouse monoclonal anti-BrdU antibody (1:500, 
Amersham, Buckinghampshire, UK) and rabbit polyclonal antibody against NG2 (1:500, 
Chemicon) at 4°C overnight. After being washed in PBS immunofluorescence staining was 
performed with species specific Alexa fluor secondary antibodies (1:1000, Molecular 
Probes) for 2h. Finally, sections were washed (3 x 7min) and mounted under glass 
coverslips using fluorescent mounting medium (DakoCymation). 
 
 
 Buffer solutions 
 
The following buffer solutions were used: 
 
1.) PBS (phosphate buffered saline) is made up of 2 different phosphate-sodium solutions, 
and contains 0.9% NaCl (AppliChem, Darmstadt, Germany). Used for applications at 
0.1M: 
Stocksolution: 0.4M (pH 7.4) 
Solution 1 (0.4M): 7.12% Na2HPO4 x 2H2O 
Solution 2 (0.4M): 5.5% NaH2PO4 x H20 
 
 
2.) TBS (Tris buffered saline) 0.05M, pH 7.4: 
0.6% Tris (Tris (hydroxymethyl)methylamine, C4H11NO3, AppliChem), 0.9%, NaCl,  
0.001% Thimerosal (C9H9HgNaO2S, AppliChem)  
 
 Transmission electron microscopy 
 
For electron microscopy, NG2-immunostained sections were processed according to 
standard procedures (Bolam, 1992). In short: NG2 immunostained sections were osmicated 
(0.5% OsO4 in 0.1M PBS, 30min), washed in PBS (3 x 5min), and dehydrated in ethanol 
(30%, 50%, 70%, each: 5min). Then, sections were contrasted (70% ethanol containing 1% 
uranyl acetate) and onward dehydrated in an ascending ethanol series (80%, 90%, 96%, 
100%, each: 10min). Then, the sections were embedded two times in propylene oxide 
(5min), followed by a mixture of propylene oxide/durcopan (1:1, 1h), and finally, in 100% 
Durcopan over night (Durcopan ACM-Kit 44610-1EA, Fluka, Taufkirchen, Germany). For 
sectioning, sections were embedded in blocks and ultrathin sections were collected on 
single-slot Formvar-coated copper grids, and examined using a Zeiss electron microscope 
(EM 109, Zeiss). 
 
 
Bromo-deoxyuridine injection 
 
5´-bromo-2´-deoxyuridine (BrdU) is a thymidine analog which is selectively incorporated 
into the DNA of proliferating cells providing a marker for the DNA being replicated. The 
number, and the identity of proliferating cells can be detected in tissue sections by, e.g. 
immunoflurescensce staining. In this study, BrdU-labeling was employed to detect NG2-
cells generated after ECL. Control and lesioned rats received intraperitoneal injections of 
BrdU (Sigma-Aldrich; BrdU dissolved in 0.9% NaCl with 0,025M NaOH; 50mg/kg body 
weight) for 9 days, beginning on the day of lesioning. On day 10 after ECL animals were 
deeply anesthetized and perfused (4% paraformaldehyde, 0.1 M PB). 
 
 
Digital processing of illustrations  
 
All photographic images were obtained using a digital camera and subsequently processed 
using a commercial available graphics software (Adobe Photoshop 6.01). Single 
fluorescent images of the same section were digitally superimposed. All images required 
minor adjustment of contrast, brightness, and sharpness. No additional image alteration 
was performed.  Results  
 
 
Amount of NG2 mRNA is significantly increased in the denervated outer molecular 
layer  
 
To determine whether and to which extent the expression of NG2 mRNA is regulated 
following entorhinal denervation, the amount of NG2 mRNA was quantified in the OML at 
different time-points following ECL. Laser microdissection of the OML was employed to 
collect tissue specifically from the zone of denervation and qPCR was used to measure 
NG2 mRNA levels in these tissue samples (Fig. 7 b, c).  
 
OMLs from three section per animal were collected. In total, four animals were used per 
time-point. The OMLs of the non-lesioned animals were used as controls and the NG2 
level of these tissue samples was used as reference level (equivalent: one). NG2 mRNA 
expression levels were measured at 6h, 12h, 2d, 4d, and 7 days post lesion and compared to 
control levels (Fig. 7 c). Relative quantification of NG2 mRNA levels revealed no 
significant increase of NG2 mRNA at 6h and 12h. However, at 2 days post lesion and 4 
days post lesion a 2.5-fold and a 2.0-fold increase of N G2 mRNA expression levels was 
detected, respectively (Fig. 7 c). At 7 days post lesion, NG2 mRNA expression had 
returned to control values (Fig. 7 c). 
In summary, the amount of NG2 mRNA in the denervated OML was significantly 
increased by 2 and 4 days post lesion compared to amount of NG2 mRNA in control rats.  
  
 
Figure 7 Significant increase of NG2 mRNA expression levels in the outer molecular layer following 
entorhinal cortex lesion 
 
a, b.   Frontal section of the rat fascia dentata stained with toluidine blue. Same section before (a), and 
after (b) LMD of the OML. The asterisk indicates the area of the collected tissue piece that had been cut.  
c.   Quantitative RT-PCR for NG2 mRNA in microdissected OMLs. Relative quantification of NG2 
mRNA expression levels showed statistically significant increases (p<0.05) of NG2 mRNA by day 2, and 
day 4 post lesion compared to controls (CO). Error bars: standard deviation (SD), Scale bars: 200µm 
 
CA3: hippocampal subfield CA3, ECL: entorhinal cortex lesion, GCL: granule cell layer, H: hilus, IML: 
inner molecular layer, LMD: lasermicrodissection, OML: outer molecular layer.  NG2-positive cells are regularly distributed in the dentate gyrus of control rats 
 
In adult rats without lesion, NG2-positive cells were found throughout the entire fascia 
dentata. These cells appeared to be regularly distributed throughout the dentate gyrus (Fig. 
8 a). Numerous NG2-positive cells were present in all regions of the dentate gyrus, without 
any conspicuous accumulation in any layer. Additionally, no differences in the intensity of 
the NG2 immunostaining could be observed between the layers of the dentate gyrus. 
 
Within the molecular layer the distribution of NG2-positive cells was also regular (Fig. 8 a, 
c). The molecular layer could not be subdivided into the IML and the OML, because no 
border between the IML and OML was detectable on the basis of the NG2 immunostaining 
(Fig. 8 c). In the granule cell layer, NG2-positive cell bodies were infrequently found. The 
NG2-positive immunostaining, which was observed in the granule cell layer, usually 
originated from pervading processes of NG2-positive cells that were located in 
neighbouring layers: the subgranular zone and the IML. In the subgranular zone some 
NG2-immunopositive cells were found. Higher magnification revealed the typical cellular 
morphology of single NG2-positive cells: Both, in rats without lesion and in rats with ECL, 
NG2-positive cells exhibited an oval cell body that measured 10 - 12µm in diameter. From 
the NG2 cell soma, several radially oriented processes extended outwards in all directions. 
The processes of NG2-positive cells were highly ramified and frequently more than 60µm 
long (Fig. 8 c). The intensity of the immunostaining of NG2-positive cells was very similar 
in all layers, i. e. no difference in the staining intensity of single NG2-positive cells was 
observed between the layers of the fascia dentata (Fig. 8 a, c). In contrast to lesioned rats, 
no NG2-positive staining was observed in the neuropil surrounding NG2-positive somata 
and processes in control rats (Fig. 8 a, c). 
 
 
Staining of NG2-positive cells is enhanced in the denervated outer molecular layer 
 
The distribution and staining pattern of NG2-positive was investigated at different time-
points following lesion (1, 4, 7, 10, 14, 30 days post lesion, and 6 month post lesion). 
Following ECL, the regular pattern of NG2-immunostaining in the dentate gyrus was 
changed: 
 At 1 day post lesion, an increase in NG2-immunostaining was barely detectable in the 
molecular layer. Only a weak difference in the intensity of the immunostaining was 
observed within the molecular layer, e.g. between the OML and IML (Fig. 8 d). However, 
at 4 days post lesion NG2-immunostaining was qualitatively enhanced in the denervated 
OML, whereas the intensity of NG2-immunostaining in the IML was not (Fig. 8 e). In 
contrast to the OML, the intensity of NG2-immunostaining in the IML appeared to remain 
at control levels. A further qualitative increase in NG2-immunolabeling was observed in 
the OML at 7 days post lesion, and at 10 days post lesion (Fig. 8 f, g). At 10 days post 
lesion, the immunostaining for NG2 reached its maximum intensity in the OML (Fig. 8 b, 
g). Thereafter, at 14 days post lesion and at 30 days post lesion, NG2-immunolabeling in 
the OML gradually decreased (Fig. 8 h, i), and returned to control levels within 6 month 
post lesion (Fig. 8 j).  
 
As described above, the intensification of NG2 immunostaining was observable 
specifically in the denervated OML. In the other layers of the dentate gyrus, e.g. the IML, 
no enhanced immunostaining was detectable at any time-point following the lesion. In 
other words, enhanced NG2-immunostaining in the denervated OML was restricted to the 
denervated OML, and was not found in other layers of the fascia dentata.  Since the 
increase in NG2-staining in lesioned animals was highly localized to the denervated OML, 
the OML could readily be delineated from the non-denervated IML (Fig 8 b). Hence, at 4, 
7, and 10 days post lesion, the border between the OML and the IML was clearly 
discernable (Fig. 8 e, f, g).   
 
Figure 8 NG2 immunohistochemistry of the rat fascia dentata at different time points following lesion 
 
a, b.  Fascia dentata of a control rat (a) and a rat 10 days after ECL (b) stained for NG2. Whereas NG2-
immunostaining is fairly homogeneous in the control (a), it is clearly enhanced in the OML of the lesioned 
animal (b). Note that the increased immunolabeling of the OML sharply delineates the denervated zone from 
the non-denervated IML (arrowheads). 
c – j.  Portions of the fascia dentata of a control animal (c) and animals at different time-points following 
lesion. 1 day (d), 4 days (e), 7 days (f), 10 days (g), 14 days (h), 30 days (i), and 6 months (j). Compared to 
controls, NG2-immunostaining is qualitatively enhanced in the OML by 1dpl, strongest around 10dpl, and 
returned to control levels within 6 month pl. Scale bars: a, b: 200µm; c - j: 30µm 
CA3: hippocampal subfield CA3, dpl: days post lesion, ECL: entorhinal cortex lesion, GCL: granule cell 
layer, H: hilus, IML: inner molecular layer, OML: outer molecular layer, pl: post lesion. The neuropil of the denervated outer molecular layer is enriched with NG2 following 
entorhinal cortex lesion 
 
At higher magnification, the morphology of single NG2-positive cells could be analysed. 
At this level of resolution, "cloudy" NG2-positive material was revealed in the neuropil 
surrounding the NG2-positive cell bodies and processes following ECL (Fig. 9 c). In 
control animals without lesion, no NG2-immunostaining was observed in the tissue 
surrounding the NG2-positive cell bodies (Fig. 9 a). Likewise, the tissue between their 
processes was unstained. In the control situation, the NG2-positive cells showed a clear 
and distinct staining of their cell bodies and processes (Fig. 9 a). In contrast, a dense 
cloudy staining appeared around NG2-positive cells and their processes between 4 days 
post lesion and 14 days post lesion (Fig. 8 e - g). This cloudy staining emerged exclusively 
in the OML. It increased with time following ECL between 1, 4, and 7 days, and reached a 
maximum of intensity at 10 days post lesion (Fig. 8 b, g, 9 c). Finally, at 6 months post 
lesion the cloudy staining had disappeared around the NG2-positive cells in the OML (Fig. 
8 j, 9 b).  
 
The appearance of these NG2-positive clouds suggest that NG2 might be released into the 
ECM of the denervated OML. To test this, electron microscopy was performed of NG2-
positive cells in the denervated OML 10 days post lesion.  
  
 
Figure 9 Morphology of NG2-positive cells in the outer molecular layer of control and lesioned rats 
 
a.  NG2-positive cell in the OML of a control animal. The cell body (arrow) and several processes of 
the cell are distinctly labeled. Note, that the space between the processes of the NG2-positive cell does not 
contain immunocytochemically detectable amounts of NG2.  
b.  NG2-positive cell in the OML at 6 month pl. The morphology of this cell closely resembles that of 
the NG2- positive cells found in controls.  
c.  NG2-positive cells in the OML and IML at 10dpl. The somata of individual NG2-positive cells can 
readily be recognized (arrow). NG2-positive processes located in the OML are surrounded by clouds of NG2-
immunopositive material (asterisk), suggesting that NG2 is secreted into the surrounding extracellular matrix.  
Scale bars: 10µm; dpl: days post lesion, IML: inner molecular layer, OML: outer molecular layer, pl: post 
lesion Electron microscopy of NG2-positive cells in the outer molecular layer: 
Immunoprecipitate in the extracellular matrix surrounding glial and neuronal 
profiles 
 
Electron micrographs of NG2-positive cells in the OML 10 days post lesion revealed a 
close association of NG2-immunoprecipitate with glial surfaces. Characteristically, 
immunoprecipitate was found on the plasmalemma of NG2-positive glial cells in the 
denervated OML (Fig. 10 a - c). These cells typically showed a fairly large (8 x 12µm) and 
more or less ovoid nucleus surrounded by a thin ring of cytoplasm (10 a). From the cell 
soma several NG2-immunopositive processes extended outwards into the surrounding 
neuropil (10 a, b, c). In some cases, a weak staining of NG2-immunoprecipitate attached to 
intracellular membranes was also observed (Fig. 10 b). To verify this observation, further 
analysis using immunogold techniques will be required. Interestingly, immunoprecipitate 
was also observed in the extracellular matrix surrounding various profiles in the neuropil 
(Fig. 10 d, e). NG2- immunoprecipitate was closely associated with glial as well as 
neuronal structures. It could be observed in the extracellular matrix surrounding synapses 
(Fig. 10 d), degenerating boutons (Fig. 10 d), spines (Fig. 10 d, e), and dendrites (Fig. 10 
f). 
 
  
 
Figure 10 Electron micrographs of NG2-immunopositive structures in the outer molecular 
layer 10 days after entorhinal cortex lesion 
 
a.  Electron micrograph of a NG2-positive cell in the OML following ECL. The soma 
is indicated by arrowheads. Boxed areas are shown at higher magnification in b, and c. 
 
b,  c.  Higher magnification of the NG2 processes in a (framed areas). The NG2-
immunoprecipitate is associated with the plasmalemmal surface of the cell (arrowheads).  d. NG2-immunoprecipitate  (arrowheads)  found in the extracellular matrix surrounding 
a degenerating axon terminal (A), which forms a synapse with a postsynaptic spine (S). A 
glial process (G) is present in the vicinity. 
 
e.  NG2-positive material is found in the neuropil (arrowhead). The surface of 
numerous profiles is labeled.  
f.  NG2-immunoprecipitate surrounds a putative dendrite (D). A presynaptic terminal 
forms a synapse (arrow) with the dendritic shaft.  
 
Scale bars: a: 2µm; b: 0.25µm, c: 0.1µm; d: 0.25µm; e: 0.25µm; f: 0.5µm;  
ECL: entorhinal cortex lesion, OML: outer molecular layer 
 NG2-positive cells do not express astroglial, microglial, and adult oligodendroglial 
markers  
 
In order to determine the cellular identity of the glial cell type producing NG2 in the 
denervated zone following ECL, double-immunofluorescence was used. NG2 
immunostaining was combined with the following markers for glial cell types that could 
produce NG2 in the brain:  
 
1.) GFAP and S100 Beta for astrocytes. The staining of GFAP- positive astrocytes depends 
on the phosphorylation status of the glial fibrillary acid protein (Stichel et al., 1991). For 
this reason, double-labeling experiments were also performed with the astrocyte marker 
S100 Beta.  
 
2.) IBA1 for microglia/macrophages 
 
3.) PLP for adult oligodendrocytes, and PDGFR-α for oligodendrocyte precursor cells.  
 
Sections were analysed using confocal microscopy to unequivocally identify double-
labelled cells. In case of the PDGFR-α/NG2 double-immunofluorescence experiments, no 
specific PDGFR- α staining of oligodendrocyte precursor cells could be obtained (data not 
shown). In case of the S100 Beta/NG2 double-immunofluorescence experiments, S100 
Beta-positive astrocytes were labeled, but these cells were not double-labelled with NG2 
(data not shown). Thus, no conclusive results were obtained in these experiments.  
 
In the double-labeling experiments of NG2 with one of the other three glial markers (i.e. 
GFAP, IBA1, PLP) no colocalisation was found. Although the OML of control and EC-
lesioned rats was carefully scanned and all cell populations were robustly stained, no 
double-labeling of NG2-positive cells with any of these three markers was observed in the 
molecular layer (Fig. 11 a - f). This suggests, that NG2-positive cells do not express typical 
markers for astrocytes, microglia/macrophages or adult oligodendrocytes in the unlesioned 
as well as the denervated dentate gyrus. Thus, NG2-positive cells could represent a distinct 
glial cell type.   
 
Figure 11 Double-labelings of NG2-positive cells in the fascia dentata 10 days post lesion 
for astroglial (GFAP), microglial (IBA1), and oligodendroglial (PLP) markers a, b.  Portion of the fascia dentata stained for NG2 (red) and the astroglial marker GFAP 
(green). Confocal microscopy revealed that NG2 did not label astrocytes.  
 
c, d.  Portion of the fascia dentata stained for NG2 (red) and the microglial marker IBA1 
(green). NG2 and IBA1 labelled distinct cell populations.  
 
e, f.   Portion of the fascia dentata stained for NG2 (red) and the oligodendroglial marker 
PLP (green). There was no overlap of NG2 and PLP-positive structures. 
 
Scale bars: a, c, e: 150µm; b, d, f: 10µm. 
GFAP: glial fibrillary acid protein, IBAI: ionised calcium binding adapter molecule 1; 
PLP: myelin phospholipid protein 
 A subpopulation of NG2-positive cells is generated postlesion in the outer molecular 
layer  
 
To receive an impression whether the increase of NG2 mRNA and the accumulation of 
NG2-immunoreactivity in the OML could be caused, at least in part, by the generation of 
new NG2-positive cells, incorporation of BrdU was studied after ECL. Control rats and 
EC-lesioned rats received BrdU injections for 9 consecutive days (beginning on the day of 
lesioning) and were transcsardially perfused at day 10 post lesion. Then, sections were 
double-labeled for NG2 and BrdU, and analysed using confocal microscopy to 
unequivocally identify double-labelled cells. In control rats, no NG2/BrdU double-labeled 
cells were found in the OML. In these animals, BrdU-positive cells were rarely found in 
the subgranular zone, the zone of hippocampal neurogenesis. None of these cells was 
NG2-positive (Fig. 12 a).  
In contrast, in rats with ECL several BrdU/NG2-double-labeled cells were additionally 
found in the OML indicating that some NG2-positive cells are generated post lesion (Fig. 
12 b). This suggests that generated cells could contribute to the increase of NG2 mRNA 
and protein observed in the denervated OML of the dentate gyrus. 
 
 
 
Figure 12 Double-labeling of NG2-positive cells with the proliferation marker 5´-bromo-
2´-deoxyuridine in the dentate gyrus of unlesioned control and after 10 days post lesion 
 a.  Portion of a non-denervated rat fascia dentata (control) stained for NG2 (red) and 
the proliferation marker BrdU (green). Confocal microscopy revealed no double-labeled 
cells. The arrow points to a BrdU-positive nucleus in the subgranular zone. 
 
b, c.  Portion of a denervated rat fascia dentata (10dpl) stained for NG2 (red) and the 
proliferation marker BrdU (green). Confocal microscopy revealed some double-labeled 
cells in the OML. The asterisk indicates two NG2/BrdU double-labeled cells. These cells 
were generated during the postlesional period. Higher magnification of these NG2/BrdU 
double-labeled cells shown in c.  
 
Scale bars: a, b: 50µm, c: 20µm 
BrdU: 5´-bromo-2´-deoxyuridine, dpl: days post lesion, ECL: entorhinal cortex lesion, 
OML: outer molecular layer 
 Discussion  
 
 
Summary of results 
 
To study the role of the CSPG NG2 for the reorganization of the adult dentate gyrus 
following ECL, the distribution pattern of the CSPG NG2 was analysed at different time-
points post lesion on the mRNA and protein levels. Electron microscopy was performed to 
localize NG2 on the ultrastructural level. NG2 producing cells were further characterised 
using double-labeling with glial markers for astrocytes, microglia/macrophages and adult 
oligodendrocytes. Finally, it was investigated whether some of the NG2-positive cells are 
generated post lesion using the proliferation marker BrdU.  
 
Lasermicrodissection and subsequent qPCR of the OML revealed a significant increase of 
the amount of NG2 mRNA at day 2 and day 4 post lesion. Immunohistochemistry of NG2 
protein was highly increased specifically in the OML between day 4 and day 10 post 
lesion. This layer-specific increase resulted in a sharp NG2-positive border between the 
denervated OML and the non-denervated IML. Furthermore, a cloudy staining was clearly 
detectable around the cell bodies and processes of NG2-positive cells at 10 days post 
lesion. Ultrastructural analysis of NG2-positive cells at 10 days post lesion revealed NG2 
immunoprecipitate not only on glial surfaces but also in the ECM surrounding neuronal 
and glial structures. The double-labelings of NG2-positive cells with glial markers for 
astrocytes, microglia/macrophages, and adult oligodendrocytes did not show any 
colocalisation of NG2-positive cells with GFAP, IBAI, or PLP. Finally, incorporated BrdU 
showed that some NG2-positive cells are generated following ECL. 
After some methodological considerations, the data will be discussed in the context of the 
axonal growth regulating properties of NG2. Finally, a role for NG2 in the denervated 
dentate gyrus will be proposed.  
 
 
Methodological considerations  
 Combined lasermicrodissection and quantitative RT-PCR 
 
General aspects 
 
Standard precautions during LMD and subsequent qPCR were reviewed in detail by Fink 
et al. (Fink and Bohle, 2002). Briefly, all solutions must be prepared with RNAse-free 
water and all nescessary equipments should be sterile. To effectively remove nucleic acid 
contaminations or RNAses, all contact areas must be carefully cleaned, e.g. with the 
commercially available RNAseZap (Sigma). To decrease the risk of contamination with 
nonnative DNA and as a result false positive findings, tissue preparation, microdissection, 
and RNA isolation should be separated from RT-PCR reactions. Therefore, work should 
only be done in separately designated RNA-areas, including the site where microdissection 
is performed, each equipped with a separate set of tools. Certainly, standard molecular 
biology rules must be followed. Noteworthy, the requirement of the toluidine blue solution 
is to be filtered in order to ensure the application of a sterile solution onto the slide. 
Furthermore, PET-foils stretched on a metal frame need to be autoclaved to avoid tissue 
contamination. To ensure that each single frame remains sterile, it is advisable to wrap 
each slide in an aluminium foil before autoclaving. Finally, the whole LMD procedure 
should last no longer than 2h to minimize the risk of RNA degradation. If all of these rules 
are observed, RNA degradation can be minimized. 
 
Morphology, section thickness, and staining procedure 
 
By using the Leica AS LMD system one is restricted to sections placed directly on a PET-
foil stretched on a metal frame. Therefore, it was necessary to verify the morphology and 
quality of sections mounted on foil after application of standard histochemical stains. The 
morphological quality of sections after staining depended on their thickness, with thinner 
sections resulting in better quality. Therefore, section thickness should be minimized to 
improve staining. However, to reduce the time needed to collect a sufficient amount of 
tissue, section thickness should be maximized. The maximal section thickness itself was, in 
turn, limited by the force of the ultraviolet laser beam. Taken together, section thickness 
had to be balanced between requirements for good morphological quality and the maximal 
yield of tissue during LMD. Optimal results lead to a good staining and a good mRNA 
amount during LMD, and could be achieved using brain sections with a thickness of 20µm. These sections were mounted on PET-foil, fixed with acetone, and finally stained with a 
modified toluidine blue staining, based on the original protocol by Romeis (1968). The 
fixation of the sections with acetone has, compared to non-alcoholic fixatives, a low rate of 
nucleic acid degradation and a preservative effect on RNA (Goldsworthy et al., 1999), and 
offered best morphological results with the toluidine blue staining. Since RNA degradation 
is known to occur primarily in an aqueous environment, staining time in watery solution 
could be decreased to 1min with no effect on staining quality. Furthermore, drying sections 
on a heater at 40
0C for 5min after staining procedure reduced the exposure of RNA to 
aqueous media, thereby minimizing RNA degradation during LMD preparation steps. 
 
 
Total RNA isolation, reverse transcription, and quantitative RT-PCR 
 
In this study the RNeasy Mini Kit (Quiagen) was used. No differences in RNA extraction 
were observed between the commercially available kits (ProPure, Arcturus; RNeasy Mini, 
Quiagen) or employing phenol/choloroform extraction utilizing Tri Reagent (Sigma) 
(Burbach et al., 2003). However, the RNeasy Mini Kit is advantageous since it offers the 
possibility for on site DNA digestion. This reduces the risk for RNA degradation because a 
DNA digestion step can be avoided. This step is necessary to avoid genomic DNA 
contamination if primers are selected within one 3´ exon region of the gene of interest and 
RNA and genomic DNA are not distinguishable during PCR. In this study, however, NG2 
primers and an intron-spanning probe bridging the border between Exon 6 and Exon 7 of 
the NG2 gene were selected ensuring the specific detection of rat NG2 mRNA without 
amplification of genomic DNA. Additionally, the use of random hexamers is advisable, 
since this assures the transcription of all fragments even if minimal RNA degradation is 
present.  
 
Quantitative RT-PCR after LMD of defined cell populations is a recently developed 
technique employed for gene expression profiling (Fink et al., 1998; Fink and Bohle, 
2002). In this study, the relative quantification of gene expression levels was established 
by calculating fold-differences between control and target samples, since the absolute 
quantification of gene expression changes does not offer any further scientifically relevant 
information. After confirming the reproducibility of several assays utilizing standard curve 
analysis, gene expression was calculated by applying the comparative CT-method using arithmetic formulas to achieve the same result as the standard curve method (Applied 
Biosystems, User Bulletin #2: Relative Quantification of Gene Expression). This approach 
is particularly valuable if cDNA amounts are limited, which is the case if limited amounts 
of lasermicrodissected tissue are available. 
 
Immunohistochemistry 
 
In the presented study two different types of NG2 antibodies were used: a polyclonal and a 
monoclonal antibody. In short, polyclonal antibodies are usually raised in rabbits and 
produced by different b-lymphocytes. As a consequence, polyclonal antibodies are 
immunochemically heterogenous and react to different epitopes of the antigen against 
which they were generated. Monoclonal antibodies are usually raised in plasma cell clones 
(hybridoma cells) of mice and are immunochemically identical. Therefore, they react to 
only a single epitope of the antigen against which they were generated. The specificity of 
an antibody needs to be verified prior to its use and there are different methods to test its 
specificity. One method is the classical process of elimination, in which the staining 
procedure is performed sequentially without the individual reagents of the specific 
protocol. Additionally, one could perform pre-adsorptions experiments with the specific 
peptide or the protein that was used to generate the antiserum or the monoclonal antibody. 
The antibody should bind to this peptide which should result in an absence of staining.  
 
The immunogenic peptides that were used to genereate the NG2 mono- and polyclonal 
antibodies were not commercially available. Therefore, the specificity of the NG2 
antibodies was tested using the classical process of elimination, i. e. either the primary or 
the secondary antibody were omitted. Furthermore, the specificity of the commercially 
available polyclonal NG2 antibody (Chemicon) has been repeatedly tested using Western 
blot analysis (Davies et al., 2004). Additionally, the distribution of NG2-positive cells 
observed with the Chemicon antibody corresponds to the distribution of NG2-positive cells 
in the hippocampus as published by others, using the antibody generated by Stallcup (Bu et 
al., 2001). The monoclonal antibody against NG2 (Chemicon) used in the study was 
generated against a cell line expressing a truncated form of NG2, which is > 280kDa. The 
specific epitope of NG2 recognizing by the monoclonal antibody has not yet been 
published, but immunostainings of control sections using the monoclonal antibody resulted 
in the same cellular labeling pattern as with the polyclonal antibody. However, immunostainings of denervated sections did not show the "cloudy precipitate", suggesting 
that the monoclonal antibody does not recognize all forms of proteolytically cleaved NG2. 
Does NG2 affect axons within the zone of denervation? Regulation of branching and 
axonal complexity  
 
In previous studies, changes of NG2-positive cells were studied at lesion sites and 
correlated with cellular and axonal growth processes occurring in the microenvironment of 
the glial scar (Norton et al., 1992; Kreutzberg, 1996; Levine et al., 2001; Chen et al., 
2002a). Jones and coworkers (2002) reported that NG2-positive cells accumulated in the 
glial scar after spinal cord injury within 1 day, reached a maximum by 7 days, and 
remained elevated for weeks thereafter (Jones et al., 2002). Since the upregulation of NG2 
temporally and spatially coincided with axonal regeneration failure and since NG2 has 
strong axon growth-inhibiting properties in vitro, it was suggested that NG2 could be a 
major obstacle for axonal regeneration (Fidler et al., 1999; Levine et al., 2001; Jones et al., 
2003; Sandvig et al., 2004).  
 
In the present work the ECL model was used to study postlesional changes of NG2 in a 
denervated zone: the denervated OML of the fascia dentata. Following ECL entorhinal 
axons degenerate resulting in a denervation of their target zone. Fibers from other brain 
areas that terminate in the OML (e.g. fibers from the contralateral entorhinal cortex and 
fibers from the medial septum) sprout new axon collaterals between 7 to 10 days post 
lesion. By 30 days post lesion these fibers have reinnervated the denervated OML and the 
sprouting process is complete (Lee et al., 1977; Loesche and Steward, 1977; Nadler et al., 
1977; Deller and Frotscher, 1997).  
 
A significant upregulation of NG2 mRNA was observed at day 2 and day 4 post lesion 
specifically in the denervated OML. At the protein level, NG2 accumulation was clearly 
detectable by day 4 post lesion, reached a maximum by 10 days post lesion and returned to 
control levels between 30 days and 6 months post lesion. Thus, NG2 was strongly 
upregulated within the denervated OML of the fascia dentata during the period of lesion-
induced axonal growth. Interestingly, the time course of NG2 mRNA upregulation and of 
NG2 protein accumulation in the OML, are different. Whereas NG2 mRNA is maximally 
increased at 2 and 4 days post lesion, the immunohistochemically detectable maximum of 
NG2 protein accumulation is not until 10 days post lesion. However, this time span have been shown for several CSPGs or ECM molecules in the denervated OML and could be 
explained by (1) the complex synthesis of chondroitinsulfate proteoglycans and by (2) the 
accumulation of the protein in the ECM of the denervated OML (Haas et al., 1999; Thon et 
al., 2000). Whereas mRNA levels may return to normal levels after day 4, the the full-
length CSPG may accumulate in the denervated zone. In any case, NG2 mRNA amount 
and NG2 immunoreaction was significantly increased in the denervated OML during the 
time of collateral sprouting. Thus, accumulation of NG2 does not seem to impede this form 
of axonal growth, and collateral sprouting does occur in spite of the presence of NG2 in the 
zone of denervation.  
 
The coincidence of NG2 upregulation and axonal regeneration failure at a CNS lesion site 
in the spinal cord on the one hand, and the coincidence of NG2-upregulation and robust 
sprouting in the denervated OML on the other hand seem to contradict each other. In the 
former case, NG2 correlates with the inhibition of axonal growth whereas in the latter case, 
NG2 correlates with the permission or the promotion of axonal growth. However, it should 
be kept in mind that the two types of axonal growth differ: Whereas axonal regeneration in 
the spinal cord following lesion is characterized by long-distance growth of injured axons, 
axonal sprouting is characterized by short-distance growth and axonal branching of 
unlesioned fibers. Nevertheless, injured axons which fail to regenerate across a lesion site 
exhibit a growth behaviour similar to that of sprouting axons following ECL. They grow 
for short distances towards the lesion site and branch off several sprouts before ceasing 
growth, a process often referred to as "regenerative sprouting" (Moore, 1974; Steward, 
1994).  
 
In the dentate gyrus, a significant increase of the degree of branching and total fiber length 
for single fibers as well as an increase in the density of axonal boutons was also 
demonstrated following ECL using the anterograde Phaseolus vulgaris leucoagglutinin 
(PHAL) (Deller et al., 1995a). Furthermore, these studies revealed alterations in the normal 
fiber morphology: Some sprouting axons develop a large number of short, truncated axonal 
processes (axonal extensions), and other fibers gave rise to conspicuous glomerular or 
tangle-like formations (Deller et al., 1995b; Deller et al., 1996c). The early appearance of 
immunoreactivity of NG2 in the OML between 4 and 14 days following lesion correlates 
with the proliferation of presynaptic processes, which begins between 4 and 6 days post 
lesion, and which is almost complete by 12 days post lesion (Steward, 1991). Thus, NG2 protein levels are highest in the OML precisely during the time period after ECL, in which 
most of the new terminals are formed, and are back to control levels when the time of 
reactive terminal formation is over. Davies and co-workers (1999) noted that the branching 
behaviour of regenerating axons in vivo correlates with the amount of CSPGs in the tissue. 
Regenerating axons that grow towards the lesion site grow up a gradient of increasingly 
CSPG-rich extracellular matrix. Since these axons become more branched as they enter 
more deeply into the CSPG-rich environment, they proposed that increasing amounts of 
CSPGs could promote the formation of axonal sprouts before acting as a stop signal at very 
high concentrations (Davies et al., 1999).  
Thus, the effect of NG2 on growing axons at a lesion site and in denervated areas of brain 
could depend on the amount of NG2 in the tissue: Whereas NG2 levels at a lesion site 
increase continuously towards the lesion centre, resulting in regeneration failure, moderate 
amounts of NG2 in a denervation zone would increase the branching of axons and permit 
local axonal growth. 
 
 
Does NG2 affect axons outside the zone of sprouting? Regulation of a layer-specific 
sprouting response  
 
The previous paragraph focused on the putative biological effects of NG2 on sprouting 
axons within the zone of denervation, where NG2 may cause the branching of axons while 
permitting local axonal growth. However, the layer-specific pattern of NG2 upregulation 
not only correlates with axonal growth in the OML but also with the failure of ingrowth of 
commissural/associational fibers from the adjacent non-denervated IML into the 
denervated zone. As shown in studies using anterograde PHAL tracing following ECL 
(Deller et al., 1995a; Deller et al., 1996a; Deller et al., 1996c; Frotscher et al., 1997), the 
denervated zone is only reinnervated by fibers that are present in the OML already before 
lesioning. Fibers from the IML fail to invade the denervated zone. 
 
A large amount of studies show that CSPGs and ECM molecules define boundaries for 
growing axons (Faissner and Steindler, 1995; Pearlman and Sheppard, 1996; Margolis and 
Margolis, 1997; Wilson and Snow, 2000; Bovolenta and Fernaud-Espinosa, 2000; Rauch, 
2004; Rhodes and Fawcett, 2004). These studies largely agree that CSPGs do not simply 
prevent axonal growth. Rather, it was demonstrated that the effects of CSPGs on axonal growth depend on the contextual situation, i.e. the presence and relative concentration of 
other growth regulating molecules, the expression of relevant receptors, and on the amount 
of CSPGs present in the matrix (Snow and Letourneau, 1992; Davies et al., 1999; Deller et 
al., 2001). Interestingly, in cases in which growing axons were given a choice situation 
between a CSPG-rich and a CSPG-poor environment, axons preferred to grow on CSPG-
poor substrates (Snow et al., 1990; Snow and Letourneau, 1992; Anderson et al., 1998; 
Snow et al., 2002).  
 
From the point of view of axons located in the IML, the situation following ECL is very 
similar to that of axons in a choice situation in vitro: These fibers are present within a 
CSPG-poor zone and would have to cross a CSPG-rich border in order to enter the 
denervated OML. Since a CSPG-rich border strongly repels growing axons (Snow and 
Letourneau, 1992), it is conceivable that this border could prevent the ingrowth of IML 
fibers into the denervated OML, thereby creating the layer-specific sprouting pattern 
observed after ECL.  
 
 
Secretion of cleaved NG2 into the zone of sprouting 
 
The dentate gyrus at 7 and at 10 days following lesion exhibited not only a strong staining 
of the NG2-positive cells in the denervated OML but also a strong immunostaining of the 
ECM. This staining of the ECM was only detectable in the denervated zone. Electron 
microscopy at 10 days post lesion in the OML revealed immunoprecipitate both on the 
plasmalemmal surface of NG2-positive glial cells and in the extracellular space 
surrounding NG2-positive cells. Interestingly, NG2-immunoprecipitate was also found in 
the surrounding of neuronal profiles, in association with vesicular structures within the 
processes, and around degenerating axon terminals. To pinpoint the precise subcellular 
localization of NG2 within the cells and on intracellular membranes, it would be necessary 
to perform immunogold-labeling. Concerning the localization of NG2 in the ECM, 
however, it is known that NG2 can be cleaved via cell surface proteolysis, probably by the 
matrix metalloproteinase MMP9 (Nishiyama et al., 1995). Furthermore, cleaved NG2 is 
found in the zone of glial scars in the spinal cord (Asher et al., 2001; Jones et al., 2002). 
The data suggests that NG2 is cleaved in the zone of sprouting following lesion of the 
entorhinal cortex with the following sequence of events: (1) In reaction to the injury, NG2 is first cleaved, (2) released into the ECM, and (3) these short forms of NG2 attaches to 
neuronal structures. 
Regulation of ECL induced axonal growth: the role of the extracellular matrix 
 
As has been pointed out in the previous paragraphs, the effect of the extracellular matrix on 
growing axons depends considerably on the relative contributions as well as the order of 
assembly of the various proteoglycans and glycoproteins. Therefore, it should be kept in 
mind that NG2 is only one of several CSPG species found in the extracellular matrix, of 
both, the normal and the injured brain. Following ECL, layer-specific upregulation of 
several CSPGs was previously observed in the OML. Among these molecules, neurocan 
(Haas et al., 1999), brevican (Thon et al., 2000), and DSD-1 proteoglycan (Deller et al., 
1997) were prominent. The relative contribution of each of these molecules to the 
regulation of lesion-induced axonal growth in vivo remains unknown. Therefore it may be 
plausible that the removal of only one of these CSPGs from the extracellular matrix has 
little or no effect on the regulation of lesion-induced axonal growth because the presence 
of the other CSPGs may compensate for this loss. It has been recently shown that axonal 
regeneration is not enhanced following spinal cord injury in NG2-null mice (de Castro et 
al., 2005). NG2 most likely acts in concert with and probably depends on the order of 
assembly and concentration of other extracellular matrix molecules. 
 
 
NG2-positive cells: a fourth glial cell type in the brain of adult rats ? 
 
The identity of NG-positive cells under normal conditions as well as in different lesion 
models is under strong debate (Greenwood and Butt, 2003). In general, NG2-positive cells 
are discussed as a glial cell type. In vitro, their immunohistochemical identity depends on 
the tissue culture conditions they were exposed to (Levine and Stallcup, 1987). In CNS 
cultures containing serum, NG2 cells abundantly express GFAP and have a stellate 
morphology indicating that these NG2-positive cells correspond to the type 2 astrocytes 
first described in culture of optic nerve (Raff et al., 1983). In serum-free CNS cultures 
NG2-positive cells are GFAP-negative but Galactocerebroside C (GalC)-positive. GalC is 
a marker that binds specifically to oligodendrocytes and Schwann Cells (Levine and 
Nishiyama, 1996). The ability of NG2 cells to develop into either astrocytes or 
oligodendrocytes has been investigated in detail in the rat cerebellum by Levine et al. (Levine and Card, 1987). Additionally, NG2 cells are discussed as oligodendrocyte 
precursor cells (Chang et al., 2000; Chen et al., 2002a; Peters and Sethares, 2004b), 
microglia/macrophages (Kreutzberg, 1996; Bu et al., 2001; Jones et al., 2002) or as a 
completely novel glial cell type (Butt et al., 2002). Belachew and coworkers (2003) have 
shown that NG2-positive cells in the CNS can generate various cell types including 
oligodendrocytes, astrocytes, and neurons (Belachew et al., 2003). In other studies NG2-
positive cells are discussed as a type of neuronal cells (Aguirre et al., 2004). However, 
despite these controversies, there is general agreement, that NG2-positive cells contribute 
to the formation of glial scars (Fawcett and Asher, 1999; Chen et al., 2002b; Ughrin et al., 
2003).  
 
Due to the distribution of NG2-positive cells in the dentate gyrus of adult rats it can be 
excluded, that within the hippocampus formation NG2-positive cells are neurons (Amaral 
and Witter, 1995). To further enlighten the identity of NG2-positive cells in the dentate 
gyrus following ECL, double-labelings of NG2 with several glial markers for astrocytes 
(GFAP, S100 Beta), microglia/macrophages (IBAI), adult oligodendrocytes (PLP), and 
oligodendrocyte progenitors were performed.  
 
The data show that NG2 is not produced by reactive astrocytes. No colocalisation of NG2-
positive cells and GFAP-positive or S100 Beta-positive cells was found in the dentate 
gyrus, neither in controls without lesion nor at any time-point of investigation following 
lesion. Even though other CSPGs ( e.g. Neurocan) are produced by reactive astrocytes 
following ECL (Haas et al., 1999; Deller et al., 2001), and although Alonso (2005) has 
shown that GFAP-positive astroglial cells found in the glial scar after stab wound injury 
may be recruited from resident NG2-positive cells until 6 days post lesion (Alonso, 2005), 
NG2-positive cells are not GFAP-positive at any time point following lesion in the rat 
dentate gyrus. 
 
Jones and co-workers (2002) observed NG2-positive cells expressing 
microglial/macrophages markers, which takes part in formation of the glial scar following 
lesion of the spinal cord, and inhibit axonal growth (Jones et al., 2002). Therefore, it was 
tested if NG2-positive cells could be found in a zone of denervation and layer-specific 
sprouting. However, no colocalisation of NG2-positive cells with microglia/macrophages 
could be observed neither in control situation nor in the denervated OML of the dentate gyrus following ECL. Since NG2-positive cells were found in a large number around 
demyelinating lesions, they may play a role in the replacement of oligodendrocytes that 
have been lost to the disease (Gensert and Goldman, 1997; Levine et al., 2001; Tanaka et 
al., 2003; Alonso, 2005). However, the double-labelings of NG2-positive cells and the 
oligodendrocyte marker PLP revealed no colocalisation of their processes in the dentate 
gyrus neither before nor following ECL.  
 
The double-labelings of the glial cell types the dentate gyrus showed that NG2 is neither 
produced by astrocytes, nor by microglia/macrophage, nor or by adult oligodendrocytes. 
Therefore, based on the double-labeling data, NG2 cells in the dentate gyrus do not seem 
to be a subpopulation of one of the three classical glial cell types. This suggests that NG2 
cells may indeed be a fourth glial cell type as proposed by others (Butt et al., 2002). 
However, further investigations will be necessary to solve this question definitely. 
 
A subpopulation of NG2-positive cells found in the denervated OML was generated 
postlesion as judged by the incorporation of BrdU. These NG2/BrdU-positive cells were 
primarily observed in the denervated OML. In addition, some BrdU-positive cells 
(immunonegative for NG2) were also found in the subgranular zone, the zone of 
neurogenesis in the adult dentate gyrus (Cameron et al., 1995; Gould et al., 1999; 
Kempermann et al., 2004; Shukla et al., 2005). These data are in line with previous studies 
reporting proliferation following ECL of glial cells (Gall et al., 1979; Avendano and 
Cowan, 1979; Hailer et al., 1999) and neurons (Cameron et al., 1995). Since the 
postlesional generation of NG2-positive cells in the adult brain has recently been 
demonstrated at lesion sites using other lesion models (Alonso, 2005; Dzwonek, 2005), the 
data of this study suggest that NG2-positive cells are generated also in denervated areas of 
the adult brain. Although the generation of NG2-positive cells in the denervated OML can 
be concluded with confidence on the basis of the presented data, several questions remain: 
Which are the cells that give rise to NG2-cells post lesion? Are subgranular precursor cells 
involved in the generation of NG2-positive cells or do NG2-cells proliferate within the 
denervated zone? Do newly generated NG2-cells differentiate into other glial cell types or 
do they remain a "fourth glial cell type", as suggested by others (Nishiyama, 2001; Butt et 
al., 2002; Greenwood and Butt, 2003). These questions will have to be addressed in future 
studies aimed at the role of glial proliferation and neurogenesis in dentate gyrus following 
ECL. Summary and conclusion 
 
To test whether the CSPG NG2 is involved in the regulation of axonal growth processes in 
denervated areas of the brain, NG2-positive cells in the denervated rat fascia dentata 
following ECL were analyzed and data were correlated with the lamina-specific sprouting 
response of uninjured fibers. The main findings of the study can be summarized as follows:  
 
1.) NG2 is upregulated in the denervated OML of the fascia dentata by a subpopulation of 
NG2-positive glia and probably secreted into the ECM. Importantly, the time course of 
NG2-upregulation coincides with the time course of axonal sprouting. Therefore, the data 
suggest that NG2 does not prevent lesion-induced axonal growth within the denervated 
zone. Rather, NG2 could be involved in the regulation of axonal branching within the 
denervated OML.  
 
2.) The upregulation of NG2 occurs in a conspicuous spatial pattern: NG2 is selectively 
upregulated within the denervated OML, and therefore, a NG2-boundary is formed 
towards adjacent non-denervated areas. This pattern of NG2-upregulation correlates with 
the layer-specific pattern of the sprouting response, and suggests that NG2 could prevent 
fiber ingrowth into the denervated zone from the outside, i.e. from adjacent non-denervated 
areas of the dentate gyrus. 
 
3.) NG2-positive cells do not coexpress markers for astrocytes, microglia/macrophages, 
and adult oligodendrocytes. Therefore, NG2-positive cells could be a fourth glial cell type 
in the dentate gyrus that participates in the glial reaction to entorhinal denervation.  
 
4.) A subpopulation of NG2-positive cells is generated postlesion and primarily found in 
the denervated OML. Additional studies will be necessary to unravel their role in the 
reorganization of the dentate gyrus following entorhinal denervation. 
 
Taken together, these data suggest that -in combination with other CSPGs and ECM 
molecules- NG2 could be responsible for the regulation of layer-specific sprouting in the 
dentate gyrus following ECL. NG2 may regulate axonal growth in the denervated OML of the fascia dentata (1) by increasing branching within the denervated zone, and (2) by 
contributing to the CSPG barrier formed between the IML and OML. 
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Frankfurt am Main 2005 Ziel dieser Arbeit war es, die Regulation axonaler Wachstumsprozesse und die Bedeutung 
des wachstumshemmenden Chondroitinsulfat Proteoglykans (CSPG) NG2 bei plastischen 
Umbauvorgängen des ZNS besser verstehen zu können. Die zu Grunde liegende Frage 
war, ob NG2 an der Regulation axonaler Wachstumsprozesse in denervierten Zonen des 
ZNS beteiligt ist. Hierfür wurden die zeitlichen und regionalen Veränderungen von NG2 in 
der Fascia dentata der Ratte vor und zu verschiedenen Zeitpunkten nach einer Läsion des 
entorhinalen Kortex untersucht. Die Expression von NG2 wurde auf mRNA-, Protein- und 
ultrastruktureller Ebene bestimmt und mit dem postläsionalen Sprossungsverhalten 
unverletzter Axone in der denervierten äußeren Molekularschicht (OML) der Fascia 
dentata korreliert. Abschließend wurde die Identität NG2-produzierender Zellen analysiert 
und untersucht, ob es zu einer Neubildung von NG2-positiven Zellen nach der Läsion 
kommt. Die Ergebnisse zeigten eine Hochregulierung von NG2 auf mRNA und auf Protein 
Ebene, die räumlich auf die deafferenzierte OML begrenzt war. Auf ultrastruktureller 
Ebene war in der OML NG2-positives Immunoprezipitat nicht nur auf glialen 
Zelloberflächen und in der extrazellulären Matrix zu sehen, sondern auch in engem 
Kontakt zu neuronalen Strukturen. Kolokalisationen von NG2-positiven Zellen mit 
anderen glialen Zellen (Astrozyten, Mikroglia/Makrophagen und Oligodendrozyten) 
wurden weder vor noch nach der Läsion gefunden, sehr wohl jedoch einige postläsional 
neu generierte NG2-positive Zellen.  
Zusammenfassend lässt sich sagen, dass alle postläsionalen Veränderungen von NG2 (1.) 
räumlich auf die denervierte OML begrenzt waren und (2.) zeitlich mit der 
Sprossungsantwort unverletzter Fasern übereinstimmten. Dies legt nahe, dass NG2 an der 
Regulation axonaler Wachstumsprozesse in denervierten Schichten des ZNS beteiligt ist. 
Ausserdem wird vermutet, dass NG2 postläsional gespalten wird und, dass NG2-positive 
Zellen ein von Astrozyten, Mikroglia/Makrophagen und Oligodendrozyten differenter 
glialer Zelltyp sind.  
 
 
Einleitung 
 
Die Läsion des entorhinalen Kortex (ECL) der Ratte führt zu einer Degeneration der 
durchtrennten Fasern des Tractus perforans und damit zu einer Deafferenzierung der 
distalen Dendriten der OML der Fascia dentata. Die denervierten Körnerzellen werden 
anschließend von anderen, unverletzten Fasersystemen reinnerviert. Auffällig bei diesem postläsionalen Sprossungsverhalten unverletzter Axone ist ihre strenge Orientierung an der 
existierenden Schichtung der Fascia dentata. Es lässt sich folgendes beobachten:  
 
1.) Nur diejenigen Fasersysteme beteiligen sich an der Reinnervation der OML, die schon 
vor der Läsion innerhalb der deafferenzierten Schicht zu finden waren. Es sprossen 
beispielsweise Fasern des kontralateralen Tractus perforans oder Fasern des medialen 
Septums. 
 
2.) Die sprossenden Fasern bleiben streng innerhalb der existierenden Faserschichtung auf 
die denervierte OML begrenzt. Weder wachsen die Fasern der OML in die innere 
Molekularschicht (IML) ein, noch dringen umgekehrt Fasern der IML in die OML ein.  
 
Verantwortlich für diese schichtenspezifische Sprossung sollen, neben intrinsischen 
Molekülen der Neurone selbst, extrazelluläre Moleküle in der Umgebung der sprossenden 
Axone sein. Die OML wird postläsional mit verschiedenen Molekülen angereichert, wie 
z.B. Zelladhäsionsmolekülen, verschiedenen Wachstumsfaktoren und Zytokinen. Durch 
diese Anreicherung der extrazellulären Matrix (EZM) mit verschiedenen 
wachstumsfördernden und wachstumshemmenden Molekülen könnte der 
Sprossungsprozeß der unverletzten Axone auf die deafferenzierte Schicht begrenzt werden.  
 
Die vorliegende Arbeit untersucht das wachstumshemmende CSPG NG2. Moleküle dieser 
Gruppe sind dafür bekannt, lokal axonale Wachstumsprozesse zu beeinflussen. NG2 ist ein 
transmembranes, ca. 300kDa großes Molekül mit inhibitorischen Eigenschaften, wie 
verschiedene in vitro Untersuchungen an auswachsenden Axonen zeigen konnten. In vivo 
ist es vor allem in der sogenannten „glialen Narbe“ nach einer Verletzung des 
Nervensystems zu finden und soll hauptverantwortlich für das Regenerationsversagen 
durchtrennter Rückenmarksneurone sein, welche die gliale Narbe nicht durchwachsen 
können. Die Identität NG2 produzierender Zellen wird in der aktuellen Literatur kontrovers 
diskutiert. Im allgemeinen werden NG2-positive Zellen als Oligodendrozyten 
Vorläuferzellen angesehen, so wird beispielsweise auch der kommerziell erhältliche 
Antikörper gegen diesen Zelltyp deklariert. Einige Studien zeigen NG2 allerdings auch auf 
Mikroglia/Makrophagen in der glialen Narbe nach Rückenmarksverletzungen und es ist 
eine mediumsabhängige Entwicklung von NG2-positiven Zellen zu entweder Astrozyten 
oder Oligodendrozyten in vitro nachgewiesen worden.  Um die Regulation axonaler Wachstumsprozesse nach einer Läsion des ZNS und den 
Beitrag von NG2 zu diesem plastischen Umbauprozessen besser verstehen zu können, 
wurden folgende Fragen bearbeitet:  
 
1.)  Wie sind (a) die mRNA und (b) das Protein von NG2 im Hippokampus nach 
entorhinaler Läsion räumlich und zeitlich verteilt? 
2.)  Wird NG2 postläsional in die EZM der OML abgegeben ? 
3.)  Welche Zellen exprimieren NG2 im Hippokampus der Ratte? 
4.)  Werden NG2-positive Zellen im Hippokampus postläsional generiert?  
 
 
Material, Methoden und Ergebnisse 
 
Um die äußere Molekularschicht der Fascia dentata zu denervieren, wurde bei Ratten eine 
unilaterale Läsion des entorhinalen Kortex durchgeführt. Diese durchtrennt den Tractus 
perforans, dessen Fasern in der OML des Hippokampus enden. Da die Vollständigkeit der 
Läsion die Grundlage für alle nachfolgenden Versuche bildet, wurden die läsionierten 
Hirne wie folgt kontrolliert: Zuerst wurden sie bei der Entnahme makroskopisch auf 
Blutungen untersucht. Zu frühen Zeitpunkten nach der Läsion (1, 4, und 7 Tage (d)) 
wurden nur Hirne ohne auffällige Blutung weiterverwendet. Zu späteren Zeitpunkten nach 
der Läsion (10, 14, 30d und 6 Monate), musste für die Weiterverwendung eine sehr feine 
Narbe an der Läsionsstelle zu sehen sein. Diese Hirne wurden außerdem an der 
Läsionsstelle horizontal geschnitten und mussten einen unbeschädigten Hippokampus 
aufweisen. Abschließend wurden dann Frontalschnitte des Hippokampus entweder mit 
dem Fluoreszensmarker Fluoro Jade B (markiert degenerierende Axone zu frühen 
Zeitpunkten nach Läsion) oder mit Acetylcholinesterase (markiert sprossende cholinerge 
Fasern zu späten Zeitpunkten nach Läsion) gefärbt. Bei beiden Färbungen musste die OML 
deutlich kräftiger gefärbt sein, als die nicht-deafferenzierte IML.  
 
1a.) Zur Quantifizierung der NG2 mRNA Expression wurde Lasermikrodissektion mit 
anschließender quantitativer RT PCR (qPCR) kombiniert. Zu verschiedenen Zeitpunkten 
(Kontrolle ohne Läsion, 6h, 12h, 2d, 4d, 7d nach Läsion) wurde die denervierte OML mit 
dem Laser ausgeschnitten, um dann die Menge an NG2 mRNA in genau dieser Zone mit Hilfe der qPCR zu ermitteln. Diese ergab eine postläsionale Erhöhung der NG2 mRNA an 
Tag 2 (2,5-fach) und an Tag 4 (2-fach). 
 
1b.) Zur Charakterisierung des Verteilungsmusters von NG2 auf Proteinebene wurden 
Frontalschnitte des Hippokampus immunhistochemisch auf NG2 angefärbt (Kontrolltiere 
ohne Läsion, 1d, 4d, 7d, 10d, 30d und 6 Monate nach der Läsion). In den Kontrolltieren 
waren NG2-positive Zellen qualitativ gleichmäßig im Hippokampus verteilt. Jedoch schon 
am ersten Tag ließ sich eine Anreicherung von NG2 in der denervierten OML erkennen. 
Diese NG2-positive Färbung in der OML verstärkte sich am 4. Tag nach Läsion, wiederum 
am 7. Tag und erreichte am 10. Tag nach der Läsion ein qualitatives Maximum. Am 30. 
Tag sowie auch 6 Monate nach der Läsion entsprach die Färbung der Kontrollsituation.  
 
2.) Aufgrund des lichtmikroskopischen Verteilungsmusters von NG2 wurden einige Hirne 
elektronenmikroskopisch untersucht (10d nach der Läsion). Die elektronenmikroskopische 
Untersuchung von NG2-positiven Zellen zeigte Immunreaktivität auf glialen 
Zelloberflächen und im Extrazellularraum der OML, aber auch in engem Kontakt zu 
neuronalen Strukturen. 
 
3.) Die Identität NG2 exprimierender Zellen sollte mit Hilfe von Fluoreszenz-
Doppelmarkierungen von NG2-positiven Zellen mit GFAP-positiven Astrozyten, IBAI-
positiven Mikroglia/Makrophagen und PLP-positiven Oligodendrozyten festgestellt 
werden. Jedoch ließen sich weder vor noch nach der Läsion Kolokalisationen von NG2-
positiven Zellen mit einem dieser Marker für gliale Zelltypen nachweisen.  
 
4.) Mit Hilfe des Zellproliferationsmarkers Bromdesoxyuridin (BrdU) sollte schließlich 
festgestellt werden, ob NG2-positive Zellen im Hippokampus postläsional generiert 
werden. Der Einbau von BrdU in NG2-positive Zellen wurde mit Fluoreszenz-
Doppelfärbungen von NG2 und BrdU kontrolliert. Bei Tieren ohne Läsion waren nur 
wenige BrdU-positive (NG2-negative) Zellen in der subgranulären Zone zu finden. 
NG2/BrdU doppelmarkierte Zellen waren in Kontrolltieren nicht zu sehen. Zehn Tage nach 
der Läsion ließen sich jedoch einige neu gebildete NG2-positive Zellen (BrdU-positiver 
Zellkern) in der denervierten OML nachweisen. 
 
 Diskussion 
 
 
Was könnte die auf die OML begrenzte Anreicherung von NG2 während des 
Sprossungsvorgangs bedeuten?  
 
Wie anfangs beschrieben wird angenommen, dass CSPGs den Sprossungsprozess 
unverletzter Axone in der OML des Hippokampus beeinflussen können. Die Moleküle 
scheinen aber unterschiedliche Effekte auf sprossende Axone (a) innerhalb der 
deafferenzierten Schicht und (b) außerhalb dieser Schicht auszuüben. Die sprossenden 
Axone innerhalb der deafferenzierten OML befinden sich in einer Umgebung, die nicht nur 
mit NG2 angereichert ist, sondern auch eine Vielzahl anderer EZM-Moleküle, 
Zelladhäsionsmoleküle und Wachstumsfaktoren enthält. Da eine Reinnervation der 
Körnerzellen stattfindet, scheinen diese Moleküle in ihrer Gesamtheit die Axonsprossung 
in der OML zu unterstützen. Die Anwesenheit wachstumshemmender Moleküle, wie NG2, 
unterdrückt in dieser Zone die axonalen Wachstumsvorgänge nicht. So wurde in anderen 
Studien gezeigt, dass Axone in einer „wachstumshemmenden Umgebung“ wachsen 
können, wenn sie sich von Anfang an in dieser Umgebung befinden. Zusätzlich erhöht sich 
der Verzweigungsgrad wachsender Axone relativ zur Konzentration inhibitorischer 
Substrate, wie ebenfalls gezeigt wurde. Die Anreicherung mit inhibitorischem NG2 in der 
Sprossungszone der denervierten Fascia dentata könnte somit die Reinnervation der 
distalen Dendriten der Körnerzellen durch eine verstärkte Verzweigung sprossender Axone 
unterstützen. Für sprossende Axone außerhalb der deafferenzierten OML (Fasern der IML) 
allerdings ist eine mit wachstumshemmenden Molekülen angereicherte Schicht eine 
effektive Barriere, wie aus verschiedenen Studien bekannt ist. Für einwachsende Axone 
stellen solche mit wachstumshemmenden Molekülen angereicherten Zonen 
unüberwindbare Hindernisse dar. Die Anreicherung der OML mit NG2 könnte so erklären, 
wieso es nicht zur Einsprossung von Fasern aus angrenzenden Schichten kommt. 
 
Welche Rolle könnte in der EZM angereichertes NG2 für axonales Wachstum nach 
einer Läsion spielen? 
 
NG2 ist bekanntermaßen nur eines von verschiedenen Molekülen, die in der Umgebung 
von sprossenden Axonen zu finden sind. Der relative Beitrag der einzelnen Moleküle zur Regulation des läsionsinduzierten axonalen Wachstums ist nicht geklärt. Da Axone von 
NG2 -/- Mäusen keine verbesserte Regeneration nach einer Rückenmarksverletzung 
zeigen, ist es wahrscheinlich, dass NG2 zusammen mit anderen EZM Molekülen agiert und 
die jeweilige Konzentration des einzelnen Moleküls den Einfluss auf die Regulation des 
axonalen Wachstums bestimmt. Postläsional gespaltenes und in die EZM abgegebenes 
NG2 könnte aber das schichtenspezifische axonale Wachstum unterstützen. Die 
elektronenmikroskopischen Daten dieser Arbeit zeigen NG2-positives Immunpräzipitat 
nicht nur auf glialen Zelloberflächen und in der umgebenden EZM, sondern auch in engem 
Kontakt zu neuronalen Strukturen. Dies stützt die Vermutung, dass NG2 postläsional 
gespalten und in die EZM abgegeben wird. Es ist bekannt, dass NG2 in vitro 
beispielsweise durch die Matrix Metalloproteinase 9 an seiner Membrandomäne gespalten 
werden kann. Wenn es auch in vivo in der Sprossungszone postläsional gespalten wird und 
dann an neuronale Strukturen bindet, verändert es die molekulare Zusammensetzung der 
OML und könnte auf diese Weise den Sprossungsprozess der Axone auf die 
deafferenzierte Zone begrenzen. 
 
NG2-positive Zellen, ein neuer Zelltyp? 
 
Im Unterschied zu anderen CSPGs wird NG2 nicht von reaktiven Astrozyten exprimiert. 
Es wurden weder pre- noch postläsional Kolokalisationen von NG2-positiven Zellen und 
GFAP-positiven Astrozyten gefunden. Andere Doppelfärbungen zeigten auch keine 
Doppelmarkierungen von NG2 und IBAI-positiven Mikroglia/Makrophagen, wie sie in der 
glialen Narbe nach Rückenmarksverletzungen gezeigt wurden. Ebenfalls konnten keine 
NG2/PLP-positiven Doppelmarkierungen gefunden werden, was auch adulte 
Oligodendrozyten als NG2 exprimierenden Zelltyp mit großer Sicherheit ausschließt. Ein 
neuronaler Zelltyp kann aufgrund des Verteilungsmusters der NG2-positiven Zellen 
ebenfalls ausgeschlossen werden. Mit den vorliegenden Daten kann nicht gesagt werden, 
von welchen Zellen NG2 exprimiert wird. Es kann auch nicht ausgeschlossen werden, dass 
die NG2-positiven Zellen einen gänzlich neuen glialen Zelltyp darstellen, wie aktuell in 
der Literatur diskutiert wird. Es kann aber gesagt werden, dass NG2 positive Zellen in der 
Fascia dentata der adulten Ratte ein von Neuronen, Astrozyten, Mikroglia/Makrophagen, 
und adulten Oligodendrozyten klar zu differenzierender Zelltyp sind. Ein Teil dieser NG2-
positiven Zellen wird darüber hinaus erst postläsional generiert.  Zusammenfassend zeigen die in dieser Arbeit ermittelten Daten, dass die Hochregulierung 
und die Anreicherung von NG2 in der EZM sowohl räumlich als auch zeitlich mit dem 
Sprossen der Fasern in der OML und der dort stattfindenden axonalen Reorganisation 
korrelieren. Dies unterstützt die Vermutung, dass NG2 im Zusammenspiel mit anderen 
CSPGs und EZM Molekülen für die Regulation der schichtenspezifischen Sprossung im 
Gyrus dentatus der Ratte nach einer Läsion des entorhinalen Kortex verantwortlich ist. 
NG2 könnte (1) über die Erhöhung des Verzweigungsgrades der Fasern innerhalb der 
denervierten Zone und (2) über seinen Beitrag zu der molekularen Barriere zwischen der 
denervierten OML und der angrenzenden IML das Faserwachstum in der OML regulieren.  
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